http://jnci.oxfordjournals.org/content/106/1/djt319.full
<!DOCTYPE html
  PUBLIC "-//W3C//DTD XHTML 1.0 Strict//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-strict.dtd">
<html
      xmlns="http://www.w3.org/1999/xhtml"
      xml:lang="en"
      lang="en">
   <head>
      <meta http-equiv="Content-Type" content="text/html; charset=UTF-8" />
      <title>Androgen Receptor Expression and Outcomes in Early Breast Cancer: A Systematic Review and Meta-Analysis </title>
      <meta name="googlebot" content="NOODP" />
      <meta name="HW.ad-path" content="/cgi/content/full/106/1/djt319" />
      <meta content="/jnci/106/1/djt319.atom" name="HW.identifier" />
      <meta name="DC.Format" content="text/html" />
      <meta name="DC.Language" content="en" />
      <meta content="Androgen Receptor Expression and Outcomes in Early Breast Cancer: A Systematic Review and Meta-Analysis"
            name="DC.Title" />
      <meta content="10.1093/jnci/djt319" name="DC.Identifier" />
      <meta content="2014-01-01" name="DC.Date" />
      <meta content="Oxford University Press" name="DC.Publisher" />
      <meta content="Francisco E. Vera-Badillo" name="DC.Contributor" />
      <meta content="Arnoud J. Templeton" name="DC.Contributor" />
      <meta content="Paulo de Gouveia" name="DC.Contributor" />
      <meta content="Ivan Diaz-Padilla" name="DC.Contributor" />
      <meta content="Philippe L. Bedard" name="DC.Contributor" />
      <meta content="Mustafa Al-Mubarak" name="DC.Contributor" />
      <meta content="Bostjan Seruga" name="DC.Contributor" />
      <meta content="Ian F. Tannock" name="DC.Contributor" />
      <meta content="Alberto Ocana" name="DC.Contributor" />
      <meta content="Eitan Amir" name="DC.Contributor" />
      <meta content="Journal of the National Cancer Institute"
            name="citation_journal_title" />
      <meta content="JNCI J Natl Cancer Inst" name="citation_journal_abbrev" />
      <meta content="0027-8874" name="citation_issn" />
      <meta content="1460-2105" name="citation_issn" />
      <meta name="citation_author" content="Francisco E. Vera-Badillo" />
      <meta name="citation_author_institution"
            content="&#xA;Affiliations of authors:&#xA;Division of Medical Oncology &amp; Hematology, Princess Margaret Cancer Centre, Department of Medicine, University of Toronto, Toronto, Canada (FEV-B, AJT, PdG, ID-P, PLB, MA-M, IFT, AO, EA); Sector of Medical Oncology, Institute of Oncology Ljubljana, Ljubljana, Slovenia (BS); Medical Oncology Department and Translational Research Unit, Albacete University Hospital, Albacete, Spain (AO)." />
      <meta name="citation_author" content="Arnoud J. Templeton" />
      <meta name="citation_author_institution"
            content="&#xA;Affiliations of authors:&#xA;Division of Medical Oncology &amp; Hematology, Princess Margaret Cancer Centre, Department of Medicine, University of Toronto, Toronto, Canada (FEV-B, AJT, PdG, ID-P, PLB, MA-M, IFT, AO, EA); Sector of Medical Oncology, Institute of Oncology Ljubljana, Ljubljana, Slovenia (BS); Medical Oncology Department and Translational Research Unit, Albacete University Hospital, Albacete, Spain (AO)." />
      <meta name="citation_author" content="Paulo de Gouveia" />
      <meta name="citation_author_institution"
            content="&#xA;Affiliations of authors:&#xA;Division of Medical Oncology &amp; Hematology, Princess Margaret Cancer Centre, Department of Medicine, University of Toronto, Toronto, Canada (FEV-B, AJT, PdG, ID-P, PLB, MA-M, IFT, AO, EA); Sector of Medical Oncology, Institute of Oncology Ljubljana, Ljubljana, Slovenia (BS); Medical Oncology Department and Translational Research Unit, Albacete University Hospital, Albacete, Spain (AO)." />
      <meta name="citation_author" content="Ivan Diaz-Padilla" />
      <meta name="citation_author_institution"
            content="&#xA;Affiliations of authors:&#xA;Division of Medical Oncology &amp; Hematology, Princess Margaret Cancer Centre, Department of Medicine, University of Toronto, Toronto, Canada (FEV-B, AJT, PdG, ID-P, PLB, MA-M, IFT, AO, EA); Sector of Medical Oncology, Institute of Oncology Ljubljana, Ljubljana, Slovenia (BS); Medical Oncology Department and Translational Research Unit, Albacete University Hospital, Albacete, Spain (AO)." />
      <meta name="citation_author" content="Philippe L. Bedard" />
      <meta name="citation_author_institution"
            content="&#xA;Affiliations of authors:&#xA;Division of Medical Oncology &amp; Hematology, Princess Margaret Cancer Centre, Department of Medicine, University of Toronto, Toronto, Canada (FEV-B, AJT, PdG, ID-P, PLB, MA-M, IFT, AO, EA); Sector of Medical Oncology, Institute of Oncology Ljubljana, Ljubljana, Slovenia (BS); Medical Oncology Department and Translational Research Unit, Albacete University Hospital, Albacete, Spain (AO)." />
      <meta name="citation_author" content="Mustafa Al-Mubarak" />
      <meta name="citation_author_institution"
            content="&#xA;Affiliations of authors:&#xA;Division of Medical Oncology &amp; Hematology, Princess Margaret Cancer Centre, Department of Medicine, University of Toronto, Toronto, Canada (FEV-B, AJT, PdG, ID-P, PLB, MA-M, IFT, AO, EA); Sector of Medical Oncology, Institute of Oncology Ljubljana, Ljubljana, Slovenia (BS); Medical Oncology Department and Translational Research Unit, Albacete University Hospital, Albacete, Spain (AO)." />
      <meta name="citation_author" content="Bostjan Seruga" />
      <meta name="citation_author_institution"
            content="&#xA;Affiliations of authors:&#xA;Division of Medical Oncology &amp; Hematology, Princess Margaret Cancer Centre, Department of Medicine, University of Toronto, Toronto, Canada (FEV-B, AJT, PdG, ID-P, PLB, MA-M, IFT, AO, EA); Sector of Medical Oncology, Institute of Oncology Ljubljana, Ljubljana, Slovenia (BS); Medical Oncology Department and Translational Research Unit, Albacete University Hospital, Albacete, Spain (AO)." />
      <meta name="citation_author" content="Ian F. Tannock" />
      <meta name="citation_author_institution"
            content="&#xA;Affiliations of authors:&#xA;Division of Medical Oncology &amp; Hematology, Princess Margaret Cancer Centre, Department of Medicine, University of Toronto, Toronto, Canada (FEV-B, AJT, PdG, ID-P, PLB, MA-M, IFT, AO, EA); Sector of Medical Oncology, Institute of Oncology Ljubljana, Ljubljana, Slovenia (BS); Medical Oncology Department and Translational Research Unit, Albacete University Hospital, Albacete, Spain (AO)." />
      <meta name="citation_author" content="Alberto Ocana" />
      <meta name="citation_author_institution"
            content="&#xA;Affiliations of authors:&#xA;Division of Medical Oncology &amp; Hematology, Princess Margaret Cancer Centre, Department of Medicine, University of Toronto, Toronto, Canada (FEV-B, AJT, PdG, ID-P, PLB, MA-M, IFT, AO, EA); Sector of Medical Oncology, Institute of Oncology Ljubljana, Ljubljana, Slovenia (BS); Medical Oncology Department and Translational Research Unit, Albacete University Hospital, Albacete, Spain (AO)." />
      <meta name="citation_author" content="Eitan Amir" />
      <meta name="citation_author_institution"
            content="&#xA;Affiliations of authors:&#xA;Division of Medical Oncology &amp; Hematology, Princess Margaret Cancer Centre, Department of Medicine, University of Toronto, Toronto, Canada (FEV-B, AJT, PdG, ID-P, PLB, MA-M, IFT, AO, EA); Sector of Medical Oncology, Institute of Oncology Ljubljana, Ljubljana, Slovenia (BS); Medical Oncology Department and Translational Research Unit, Albacete University Hospital, Albacete, Spain (AO)." />
      <meta content="Androgen Receptor Expression and Outcomes in Early Breast Cancer: A Systematic Review and Meta-Analysis"
            name="citation_title" />
      <meta content="01/01/2014" name="citation_date" />
      <meta content="106" name="citation_volume" />
      <meta content="1" name="citation_issue" />
      <meta content="djt319" name="citation_firstpage" />
      <meta content="106/1/djt319" name="citation_id" />
      <meta content="106/1/djt319" name="citation_id_from_sass_path" />
      <meta content="jnci;106/1/djt319" name="citation_mjid" />
      <meta content="10.1093/jnci/djt319" name="citation_doi" />
      <meta content="http://jnci.oxfordjournals.org/content/106/1/djt319.abstract"
            name="citation_abstract_html_url" />
      <meta content="http://jnci.oxfordjournals.org/content/106/1/djt319.full"
            name="citation_fulltext_html_url" />
      <meta content="http://jnci.oxfordjournals.org/content/106/1/djt319.full.pdf"
            name="citation_pdf_url" />
      <meta content="/content/106/1.cover.gif" name="issue_cover_image" />
      <meta content="http://jnci.oxfordjournals.org/content/106/1/djt319"
            name="citation_public_url" />
      <meta content="24273215" name="citation_pmid" />
      <meta name="citation_section" content="Review" />
      <meta name="robots" content="noarchive,nofollow" />
      <meta name="googlebot" content="noarchive" />
      <link href="/content/105/24/NP.4.short" rel="prev" />
      <link href="/content/106/1/djt322.short" rel="next" />
      <link rel="stylesheet" type="text/css" media="all" href="/shared/css/hw-global.css" />
      <link rel="stylesheet" type="text/css" media="print" href="/shared/css/hw-print.css" />
      <link rel="stylesheet" type="text/css" media="all"
            href="/local/css/hw-local-global.css" />
      <link rel="stylesheet" type="text/css" media="all"
            href="/publisher/css/hw-publisher-global.css" />
      <link rel="stylesheet" type="text/css" media="all"
            href="/publisher/css/hw-publisher-ac.css" />
      <link rel="stylesheet" type="text/css" media="all"
            href="/shared/css/hw-page-content.css" />
      <link rel="stylesheet" type="text/css" media="all"
            href="/shared/css/jquery.fancybox-1.3.4.css" />
      <link rel="stylesheet" type="text/css" media="all"
            href="/shared/css/hw-global-colexpand.css" />
      <link rel="stylesheet" type="text/css" media="all"
            href="/publisher/css/hw-publisher-page-content.css" /><script type="text/javascript" id="session-d27364504e1">var callbackToken='5373E193B4FC23E';</script><script type="text/javascript" id="session-d27364504e3">
                      var subCode='oupjournal_sub';
                    </script><script type="text/javascript">
            var gAuthTimeStamp = '2015-10-27T12:13:41.233-07:00';
            var gSessionId = '5gWwkdnOtAEeTIxr3DuaMw';
            var gAuthzRequired = 'false';
            var gAuthnMethods1 = 'ip ip';
            var gAuthnMethods2 = 'ip,ip';
            var gAuthnIPs = '18.189.59.169,18.189.59.169';
            var gAuthnIndividuals = '';
            var gAuthnInstitutions = '10005282,10072538,10328193,100274300,10082403,05094000,10093227,153074108,10080507,21879000,10095822,10081742,10082405,10004595,10019502,10082401,07635000,10082404,06602000';
            </script><script type="text/javascript" src="/shared/js/jquery-min.js"></script><script type="text/javascript" src="/shared/js/fingerprint.js"></script><script type="text/javascript" src="/shared/js/hw-shared.js"></script><script type="text/javascript" src="/publisher/js/hw-publisher-site.js"></script><script type="text/javascript" src="/local/js/local-js-vars.js"></script><script type="text/javascript" src="/shared/js/pages/hw-content.js"></script><script type="text/javascript" src="/shared/js/fancybox/jquery.fancybox-1.3.4.js"></script><script type="text/javascript" src="/shared/js/fancybox/jquery.easing-1.3.pack.js"></script><script type="text/javascript"
              src="/shared/js/fancybox/jquery.mousewheel-3.0.4.pack.js"></script><script type="text/javascript" src="/shared/js/util/content.jquery.addVariantLink.js"></script><script type="text/javascript" src="/shared/js/util/hw-col-expand.js"></script><script type="text/javascript" src="/publisher/js/hw-publisher-modalwin-vars.js"></script><script type="text/javascript"
              src="/publisher/js/hw-publisher-article-dynamic-elements.js"></script><script type="text/javascript" src="/publisher/js/hw-publisher-content.js"></script><script type="text/javascript" src="/shared/js/util/hw-mathjax.js"></script><script type="text/x-mathjax-config">
          MathJax.Hub.Config({
              tex2jax: {
                inlineMath: [["$","$"],["\\(","\\)"]],
                processClass: "tex2jax_process|mathjax"
              }
            });
          MathJax.Hub.Queue(function() {
            gColTempResize = true;
            fixColHeights(1);
            gColTempResize = false;
          });
       </script><script type="text/javascript"
              src="http://cdn.mathjax.org/mathjax/latest/MathJax.js?config=TeX-AMS-MML_HTMLorMML"></script><script type="text/javascript">
	    
	    
	    
	    var siqDOI = encodeURIComponent("10.1093/jnci/djt319");
	    var siqIsOpenAccess = encodeURIComponent("");
	    var siqPubDate = encodeURIComponent("20140101");

	    if (siqDOI.length == 0) {
	        siqDOI = "UNKNOWN";
	    }
	    
	    
		
		
	    if (gAuthnIndividuals.length != 0) {
		if (gAuthnInstitutions.length != 0) {
		    authnEntity = encodeURIComponent(gAuthnIndividuals
		        + ',' + gAuthnInstitutions);
		} else {
		    authnEntity = encodeURIComponent(gAuthnIndividuals);
		}
	    } else {
	        authnEntity = encodeURIComponent(gAuthnInstitutions);
	    }

	    var commonString =
		'authSessionId=' + gSessionId + String.fromCharCode(0x26)
		+ 'authzRequired=' + gAuthzRequired + String.fromCharCode(0x26)
		+ 'authentication_method=' + encodeURIComponent(gAuthnMethods2) + String.fromCharCode(0x26)
		+ 'authnIPs=' + gAuthnIPs + String.fromCharCode(0x26)
		+ 'authnInstitutions=' + authnEntity;

		
		
		
		

	    var gPageId = "pageid-content";
	    var gVariant = "full-text";

	    
		// Not completely done
		var eventType = "full-text";
		var accessType;
		if (siqIsOpenAccess == 'true') {
		    accessType = 'SOA';
		} else {
		    accessType = 'subscription';
		}
		    
		var NTPT_PGEXTRA =
		    commonString + String.fromCharCode(0x26)
		    + 'event_type=' + eventType + String.fromCharCode(0x26)
		    + 'publication_date=' + siqPubDate + String.fromCharCode(0x26)
		    + 'access_type=' + accessType + String.fromCharCode(0x26)
		    + 'doi=' + siqDOI ;
		    
		

	    // alert("NTPT_PGEXTRA is " + NTPT_PGEXTRA);
	</script><link rel="stylesheet" type="text/css" media="all" href="/resource/css/hw20.css" />
      <link rel="stylesheet" type="text/css" media="all"
            href="/resource/css/h20-oup-header.css" />
      <link rel="stylesheet" type="text/css" media="all"
            href="/resource/css/h20-oup-footer.css" />
      <link rel="stylesheet" type="text/css" media="all"
            href="/resource/css/h20-oup-sidebars.css" />
      <link type="text/css" media="all" rel="stylesheet" href="/site/resource/jnci_h20.css" />
      <link rel="stylesheet" type="text/css" href="/resource/css/print.css" media="print" /><script type="text/javascript" src="/resource/js/main.js"></script><link rel="stylesheet" type="text/css" media="all"
            href="http://oi-underbar.ifactory.com/underbar/css/pf_oiunderbar.css" />
      <link rel="stylesheet" type="text/css" media="screen"
            href="http://gab.cookie.oup.com/aws-cookie/jquery.fancybox-1.3.4_1.css" /><script type="text/javascript" src="/resource/js/oup_ad_size.js"></script></head>
   <body class="general_page journal jnci">
      <div class="hw-gen-page pagetype-content hw-pub-id-article" id="pageid-content"
           itemscope="itemscope"
           itemtype="http://schema.org/ScholarlyArticle">
         <noscript>
            <p>We use cookies to enhance your experience on our website. By continuing to use our website, you are agreeing to our use of
               cookies. You can change your cookie settings at any time. <a href="http://global.oup.com/cookiepolicy/">Find out more</a></p>
         </noscript>
         
         
         <p class="hide">
            <a href="#content">Skip Navigation</a>
            
         </p>
         
         
         <div id="secondary_nav">
            <strong id="page_logo" title="Oxford Journals"><a href="http://www.oxfordjournals.org/"><span>Oxford Journals</span></a></strong>
            
            <ul>
               <li id="nav_contact_us" title="Contact Us"><a href="http://www.oxfordjournals.org/contact_us.html"><span>Contact Us</span></a></li>
               <li id="nav_my_basket" title="My Basket"><a href="https://secure.oxfordjournals.org/basket.html"><span>My Basket</span></a></li>
               <li id="nav_my_account" title="My Account"><a href="http://services.oxfordjournals.org/cgi/tslogin?url=http://www.oxfordjournals.org/service/Register"><span>My 
                        
                        Account</span></a></li>
            </ul>
            
         </div>
         
         
         <div id="header">
            
            <h1 id="page_title" title="JNCI J Natl Cancer Inst"><a href="/"><span>
                     JNCI J Natl Cancer Inst
                     </span></a></h1>
            
         </div>
         
         
         <div id="primary_nav">
            
            <ul>
               <li id="nav_about_this_journal" title="About This Journal">
                  <a href="http://www.oxfordjournals.org/jnci/about.html">
                     
                     <span>About This Journal</span>
                     </a>
                  
               </li>
               <li id="nav_contact_this_journal" title="Contact This Journal"><a href="/cgi/feedback/"><span>Contact This Journal</span></a></li>
               <li id="nav_subscriptions" title="Subscriptions">
                  <a href="http://www.oxfordjournals.org/jnci/access_purchase/buy_online.html">
                     
                     <span>Subscriptions</span>
                     </a>
                  
               </li>
               <li id="nav_current_issue" title="Current"><a href="/content/current"><span>View Current Issue (Volume 107 Issue 10 October 2015)</span></a></li>
               <li id="nav_archive" title="Archive"><a href="/content/by/year"><span>Archive</span></a></li>
               <li id="nav_search" title="Search"><a href="/search"><span>Search</span></a></li>
            </ul>
            
         </div>
         
         
         <div id="user_nav">
            
            <div class="header-ac-elements">
               
               <div id="authstring">
                  
                  <ul>
                     <li class="subscr-ref">Institution:  MIT Libraries</li>
                     <li class="no-left-border">
                        <a href="/login?uri=http%3A%2F%2Fjnci.oxfordjournals.org%2Fcontent%2F106%2F1%2Fdjt319.full">
                           Sign In as Personal Subscriber
                           </a>
                        
                     </li>
                  </ul>           
                  
               </div>   
               
            </div>
            
         </div>
         
         
         <ul id="site-breadcrumbs">
            <li class="first"><a href="http://services.oxfordjournals.org/cgi/tslogin?url=http%3A%2F%2Fwww.oxfordjournals.org">Oxford Journals</a></li>
            <li><span class="breadcrumb_subjects"><a href="http://www.oxfordjournals.org/subject/medicine/"
                     class="breadcrumb_subject">Medicine &amp; Health</a></span></li>
            <li><a href="/">JNCI J Natl Cancer Inst</a></li>
            <li><a href="/content/106/1.toc">
                  <span xmlns="" class="volume-value">Volume 106</span>
                  <span xmlns="" class="issue-value"> Issue 1</span></a></li>
            <li class="last">10.1093/jnci/djt319</li>
         </ul>
         
         
         
         
         <div id="oas_top" class="ad_hidden">
            <iframe id="id_advertframe_top"
                    src="/resource/htmlfiles/advert.html?p=Top&amp;u=jnci.oxfordjournals.org/content/106/1/djt319.full"
                    width="0"
                    height="0"
                    frameborder="0"
                    scrolling="no"
                    class="resize_ad"></iframe>
            
         </div>
         
         
         <a name="content"></a>
         
         
         <div id="h20_page"></div>
         
         <div id="content-block">
            <div class="article fulltext-view " itemprop="articleBody"><span class="highwire-journal-article-marker-start"></span><h1 id="article-title-1" itemprop="headline">Androgen Receptor Expression and Outcomes in Early Breast Cancer: A Systematic Review and Meta-Analysis</h1>
               <div class="contributors">
                  <ol class="contributor-list" id="contrib-group-1">
                     <li class="contributor" id="contrib-1" itemprop="author" itemscope="itemscope"
                         itemtype="http://schema.org/Person"><span class="name" itemprop="name"><a class="name-search"
                              href="/search?author1=Francisco+E.+Vera-Badillo&amp;sortspec=date&amp;submit=Submit">Francisco E. Vera-Badillo</a></span>, 
                     </li>
                     <li class="contributor" id="contrib-2" itemprop="author" itemscope="itemscope"
                         itemtype="http://schema.org/Person"><span class="name" itemprop="name"><a class="name-search"
                              href="/search?author1=Arnoud+J.+Templeton&amp;sortspec=date&amp;submit=Submit">Arnoud J. Templeton</a></span>, 
                     </li>
                     <li class="contributor" id="contrib-3" itemprop="author" itemscope="itemscope"
                         itemtype="http://schema.org/Person"><span class="name" itemprop="name"><a class="name-search"
                              href="/search?author1=Paulo+de+Gouveia&amp;sortspec=date&amp;submit=Submit">Paulo de Gouveia</a></span>, 
                     </li>
                     <li class="contributor" id="contrib-4" itemprop="author" itemscope="itemscope"
                         itemtype="http://schema.org/Person"><span class="name" itemprop="name"><a class="name-search"
                              href="/search?author1=Ivan+Diaz-Padilla&amp;sortspec=date&amp;submit=Submit">Ivan Diaz-Padilla</a></span>, 
                     </li>
                     <li class="contributor" id="contrib-5" itemprop="author" itemscope="itemscope"
                         itemtype="http://schema.org/Person"><span class="name" itemprop="name"><a class="name-search"
                              href="/search?author1=Philippe+L.+Bedard&amp;sortspec=date&amp;submit=Submit">Philippe L. Bedard</a></span>, 
                     </li>
                     <li class="contributor" id="contrib-6" itemprop="author" itemscope="itemscope"
                         itemtype="http://schema.org/Person"><span class="name" itemprop="name"><a class="name-search"
                              href="/search?author1=Mustafa+Al-Mubarak&amp;sortspec=date&amp;submit=Submit">Mustafa Al-Mubarak</a></span>, 
                     </li>
                     <li class="contributor" id="contrib-7" itemprop="author" itemscope="itemscope"
                         itemtype="http://schema.org/Person"><span class="name" itemprop="name"><a class="name-search"
                              href="/search?author1=Bostjan+Seruga&amp;sortspec=date&amp;submit=Submit">Bostjan Seruga</a></span>, 
                     </li>
                     <li class="contributor" id="contrib-8" itemprop="author" itemscope="itemscope"
                         itemtype="http://schema.org/Person"><span class="name" itemprop="name"><a class="name-search"
                              href="/search?author1=Ian+F.+Tannock&amp;sortspec=date&amp;submit=Submit">Ian F. Tannock</a></span>, 
                     </li>
                     <li class="contributor" id="contrib-9" itemprop="author" itemscope="itemscope"
                         itemtype="http://schema.org/Person"><span class="name" itemprop="name"><a class="name-search"
                              href="/search?author1=Alberto+Ocana&amp;sortspec=date&amp;submit=Submit">Alberto Ocana</a></span> and 
                     </li>
                     <li class="last" id="contrib-10"><span class="name"><a class="name-search"
                              href="/search?author1=Eitan+Amir&amp;sortspec=date&amp;submit=Submit">Eitan Amir</a></span></li>
                  </ol>
                  <ol class="affiliation-list">
                     <li class="aff"><a id="aff-1" name="aff-1"></a><address>
                           <strong>Affiliations of authors:</strong>
                           Division of Medical Oncology &amp; Hematology, Princess Margaret Cancer Centre, Department of Medicine, University of Toronto,
                           <span class="addr-line">Toronto</span>, Canada (FEV-B, AJT, PdG, ID-P, PLB, MA-M, IFT, AO, EA); Sector of Medical Oncology, Institute of Oncology Ljubljana, <span class="addr-line">Ljubljana</span>, Slovenia (BS); Medical Oncology Department and Translational Research Unit, Albacete University Hospital, <span class="addr-line">Albacete</span>, Spain (AO).
                        </address>
                     </li>
                  </ol>
                  <ol class="corresp-list">
                     <li class="corresp" id="corresp-1">
                        <strong>Correspondence to:</strong><br /> Alberto Ocana, MD, PhD, Medical Oncology Department and Translational Research Unit, Albacete University Hospital, Edificio
                        de Investigación, Calle Francisco Javier de Moya, 02006 Albacete, Spain (e-mail: <span class="em-link"><span class="em-addr">albertoo{at}sescam.jccm.es</span></span>).
                     </li>
                  </ol>
                  <ul class="history-list">
                     <li xmlns:hwp="http://schema.highwire.org/Journal" class="received"
                         hwp:start="2013-06-06"><span class="received-label">Received </span>June 6, 2013.
                     </li>
                     <li xmlns:hwp="http://schema.highwire.org/Journal" class="rev-recd"
                         hwp:start="2013-09-16"><span class="rev-recd-label">Revision received </span>September 16, 2013.
                     </li>
                     <li xmlns:hwp="http://schema.highwire.org/Journal" class="accepted"
                         hwp:start="2013-09-18"><span class="accepted-label">Accepted </span>September 18, 2013.
                     </li>
                  </ul>
               </div>
               <div class="section abstract" id="abstract-1" itemprop="description">
                  <div class="section-nav">
                     <div class="nav-placeholder"> </div><a href="#sec-5" title="Methods" class="next-section-link"><span>Next Section</span></a></div>
                  <h2>Abstract</h2>
                  
                  <div id="sec-1" class="subsection">
                     
                     
                     <p id="p-1"><strong>Background</strong> The androgen receptor (AR) is expressed frequently in breast cancer, but its prognostic significance is unclear. Preclinical
                        data suggest that expression of AR may modify clinical outcomes in early breast cancer with improved prognosis in estrogen
                        receptor (ER)–positive disease and poorer prognosis in ER-negative disease.
                     </p>
                     
                  </div>
                  
                  <div id="sec-2" class="subsection methods">
                     
                     
                     <p id="p-2"><strong>Methods</strong> A systematic review of electronic databases was conducted to identify studies published between 1946 and July 2012 and to
                        explore the association between AR expression and overall survival (OS) and disease-free survival (DFS) in women diagnosed
                        with early breast cancer. The odds ratios (OR) for OS and DFS at 3 and 5 years were calculated and then weighted and pooled
                        in a meta-analysis with Mantel–Haenszel random-effect modeling. All statistical tests were two-sided.
                     </p>
                     
                  </div>
                  
                  <div id="sec-3" class="subsection">
                     
                     
                     <p id="p-3"><strong>Results</strong> Nineteen studies with a total of 7693 women were included. AR expression was documented in 60.5% of patients. ER-positive
                        tumors were more likely to express AR- than ER-negative tumors (74.8% vs 31.8%, χ<sup>2</sup>
                        <em>P</em> &lt; .001). Compared with tumors without AR expression, those expressing AR were associated with improved OS at both 3 and 5
                        years (OR = 0.47, 95% confidence interval [CI] = 0.39 to 0.58, <em>P</em> &lt; .001; and OR = 0.40, 95% CI = 0.29 to 0.56, <em>P</em> &lt; .001). The absolute differences in the probability of OS at 3 and 5 years were 6.7% (95% CI = 3.5% to 9.8%) and 13.5% (95%
                        CI = 7.5% to 19.6%), respectively. Results for 3- and 5-year DFS were similar. Coexpression of the ER did not influence OS
                        at 3 or at 5 years.
                     </p>
                     
                  </div>
                  
                  <div id="sec-4" class="subsection">
                     
                     
                     <p id="p-4"><strong>Conclusions</strong> Expression of AR in women with breast cancer is associated with better OS and DFS irrespective of coexpression of ER.
                     </p>
                     
                  </div>
                  
               </div>
               <p id="p-5">Multiple studies have confirmed that expression of the estrogen receptor (ER) and progesterone receptor (PR) is associated
                  with better outcome in women with breast cancer (<a id="xref-ref-1-1" class="xref-bibr" href="#ref-1">1</a>,<a id="xref-ref-2-1" class="xref-bibr" href="#ref-2">2</a>). More recently, attention has focused on the role of androgens and the androgen receptor (AR) as prognostic markers and
                  as therapeutic targets in breast cancer (<a id="xref-ref-3-1" class="xref-bibr" href="#ref-3">3–5</a>).
               </p>
               <p id="p-6" class="indent">Therapeutic use of the androgen fluoxymesterone for women with advanced breast cancer was described more than 50 years ago
                  with reported response rates of 14% to 53% (<a id="xref-ref-6-1" class="xref-bibr" href="#ref-6">6–9</a>). Its use in combination with tamoxifen has also been studied, although clinical benefit was not observed (<a id="xref-ref-10-1" class="xref-bibr" href="#ref-10">10</a>,<a id="xref-ref-11-1" class="xref-bibr" href="#ref-11">11</a>). As a result of a lack of biological understanding of the anticancer effects of androgens, inconsistent clinical data, undesirable
                  toxicities such as virilization, and the development of aromatase inhibitors, enthusiasm for their use as treatment for breast
                  cancer diminished.
               </p>
               <p id="p-7" class="indent">More recently, in vitro data have shown that the effects of androgens may be dependent of the expression of AR. High concentrations
                  of the androgen 5α-dehydro-testosterone have seen shown to cause inhibition of proliferation and cell survival and an increase
                  of apoptosis in human breast cancer cell lines expressing both ER and AR (<a id="xref-ref-12-1" class="xref-bibr" href="#ref-12">12</a>). Activation of AR with dihydrotestosterone in such cell lines decreased estrogen-dependent signaling to a similar magnitude
                  as that seen with tamoxifen (<a id="xref-ref-13-1" class="xref-bibr" href="#ref-13">13</a>). The proposed mechanism for these findings is that after ligand binding AR translocates to the nucleus where it competes
                  with ER and PR for binding to the estrogen-related elements and thereby inhibits estrogen-dependent signaling (<a id="xref-fig-1-1" class="xref-fig" href="#F1">Figure 1A</a>) (<a id="xref-ref-14-1" class="xref-bibr" href="#ref-14">14</a>,<a id="xref-ref-15-1" class="xref-bibr" href="#ref-15">15</a>). One might therefore expect that expression of AR would be associated with reduced cell survival and promotion of apoptosis.
               </p>
               <div id="F1" class="fig pos-float type-figure  odd">
                  <div class="fig-inline"><a href="djt319/F1.expansion.html"><img alt="Figure 1." src="djt319/F1/graphic-1.small.gif" /></a><a href="djt319/F1.expansion.html"><img alt="Figure 1." src="djt319/F1/graphic-2.small.gif" /></a><div class="callout"><span>View larger version:</span><ul class="callout-links">
                           <li><a href="djt319/F1.expansion.html">In this window</a></li>
                           <li><a class="in-nw" href="djt319/F1.expansion.html">In a new window</a></li>
                        </ul>
                        <ul class="fig-services">
                           <li class="ppt-link"><a href="/powerpoint/106/1/djt319/F1">Download as PowerPoint Slide</a></li>
                        </ul>
                     </div>
                  </div>
                  <div class="fig-caption"><span class="fig-label">Figure 1.</span> 
                     
                     <p id="p-8" class="first-child">Effect of androgen receptor (AR) expression on estrogen receptor (ER)–positive and –negative breast tumors. Diagrams illustrating
                        the effects on ER-positive (<strong>A</strong>) and ER-negative (<strong>B</strong>) breast tumors are depicted. 17β-HSD = 17 β-hydroxysteroid dehydrogenase; A = androgen; ARE = androgen-related element; CYP17A1
                        = cytochrome P450 17A1; DHT = dehidrotestosterone; ERE = estrogen-related element; HSP = heat shock protein.
                     </p>
                     
                     <div class="sb-div caption-clear"></div>
                  </div>
               </div>
               <p id="p-9" class="indent">Data describing the effect of AR expression in breast cancer cells without coexpression of ER are sparse. It has been hypothesized
                  that signaling through AR replaces estrogen-dependent signaling as the major determinant of steroid-related gene expression.
                  This signaling can exert a stimulatory effect through the androgen responsive element, thereby stimulating transcription of
                  steroid-responsive genes (<a id="xref-fig-1-2" class="xref-fig" href="#F1">Figure 1B</a>) (<a id="xref-ref-16-1" class="xref-bibr" href="#ref-16">16</a>). Preclinical studies have demonstrated that androgens can lead to proliferation of AR-expressing breast cancer cell lines
                  and promote tumor formation in animal models (<a id="xref-ref-17-1" class="xref-bibr" href="#ref-17">17</a>). In one study, ER-negative/AR-positive tumors have also been associated with higher nuclear grade, increased risk of recurrence
                  and distant metastasis, and adverse survival (<a id="xref-ref-18-1" class="xref-bibr" href="#ref-18">18</a>). The ER-negative/AR-positive phenotype may also possess a specific molecular signature such as the molecular apocrine tumor
                  (<a id="xref-ref-18-2" class="xref-bibr" href="#ref-18">18</a>). However, independent validation of this signature is required because hierarchical clustering has been shown to have only
                  modest interobserver reproducibility (<a id="xref-ref-19-1" class="xref-bibr" href="#ref-19">19</a>).
               </p>
               <p id="p-10" class="indent">The magnitude and direction of association between AR expression and clinical outcome in both ER-positive and ER-negative
                  breast cancer is unclear. We report a systematic review and a meta-analysis of the influence of AR expression on clinical
                  outcomes in early breast cancer. We also assess the influence of AR in subgroups determined by expression of other receptors
                  such as ER and HER2/neu. Based on preclinical data, we hypothesized that expression of AR would modify clinical outcomes in
                  early breast cancer with an improved prognosis seen in ER-expressing tumors and a worse prognosis in ER-negative disease.
               </p>
               <div class="section methods" id="sec-5">
                  <div class="section-nav"><a href="#abstract-1" title="Abstract" class="prev-section-link"><span>Previous Section</span></a><a href="#sec-11" title="Results" class="next-section-link"><span>Next Section</span></a></div>
                  
                  <h2>Methods</h2>
                  
                  <div id="sec-6" class="subsection">
                     
                     <h3>Data Sources and Searches</h3>
                     
                     <p id="p-11">An electronic search of the following databases was undertaken: Medline (host: OVID) from 1946 to July 2012, EMBASE (host:
                        OVID) from 1946 to July 2012, and Cochrane Central Register of Controlled Trials (from inception Oct 2000 until July 2012).
                        The search was limited to English language articles. The search terms included “breast neoplasms,” “androgen,” and “androgen
                        receptor.” Citation lists of retrieved articles were manually screened to ensure sensitivity of the search strategy.
                     </p>
                     
                  </div>
                  
                  <div id="sec-7" class="subsection">
                     
                     <h3>Study Selection</h3>
                     
                     <p id="p-12">Inclusion criteria were studies in early breast cancer (as defined by individual reports) with availability of overall survival
                        (OS) data for 3 and/or 5 years or disease-free survival (DFS) data for 3 and/or 5 years. There was no restriction based on
                        study methodology. Exclusion criteria included studies in metastatic disease and duplicate publications. One reviewer (P.
                        de Gouveia) evaluated all the titles and abstracts identified by the search strategy, and all potentially relevant publications
                        were retrieved in full. Two independent reviewers (F.E. Vera-Badillo and P. de Gouveia) then assessed the articles for study
                        eligibility. Inter-reviewer agreement was assessed using Cohen’s kappa coefficient. Disagreement was resolved by consensus.
                     </p>
                     
                  </div>
                  
                  <div id="sec-8" class="subsection">
                     
                     <h3>Endpoints of Interest</h3>
                     
                     <p id="p-13">OS at 3 and 5 years were the primary endpoints. Where not available, data for DFS at 3 and 5 years were collected. Tumors
                        were classified by ER and HER2/neu expression status using cutoffs as defined by individual studies.
                     </p>
                     
                  </div>
                  
                  <div id="sec-9" class="subsection">
                     
                     <h3>Data Extraction</h3>
                     
                     <p id="p-14">Data were collected using predesigned abstraction forms. The following details were extracted by 2 reviewers (F.E. Vera-Badillo
                        and P. de Gouveia): number of patients, technique used to quantify ER and AR, and cutoff to determine ER and AR positivity.
                        Survival data were extracted from tables or the body of eligible articles or estimated from Kaplan–Meier curves where applicable
                        (<a id="xref-ref-20-1" class="xref-bibr" href="#ref-20">20</a>).
                     </p>
                     
                  </div>
                  
                  <div id="sec-10" class="subsection">
                     
                     <h3>Statistical Analysis</h3>
                     
                     <p id="p-15">Data were presented descriptively as means and proportions. Differences between groups were tested using the χ<sup>2</sup> test. The relative frequency of death or disease recurrence at 3 or 5 years between AR-positive and AR-negative tumors was
                        presented as an odds ratio (OR) with its 95% confidential interval (CI). Data were extracted from the primary publications
                        and combined into a meta-analysis using RevMan 5.1 analysis software (Cochrane Collaboration, Copenhagen, Denmark). Estimates
                        of odds ratios were weighted and pooled using the Mantel–Haenszel random-effect model. Statistical heterogeneity was assessed
                        using the Cochran’s <em>Q</em> and <em>I</em>
                        <sup>2</sup> statistics. Differences between subgroups were assessed using methods described by Deeks et al. (<a id="xref-ref-21-1" class="xref-bibr" href="#ref-21">21</a>). Sensitivity analyses were carried out for different analytical methods and cutoffs for defining ER and AR expression as
                        well as for potential heterogeneity in the definition of early (vs metastatic) breast cancer. All statistical tests were two-sided,
                        and statistical significance was defined as <em>P</em> less than .05. No correction was made for multiple statistical testing.
                     </p>
                     
                  </div>
                  
               </div>
               <div class="section" id="sec-11">
                  <div class="section-nav"><a href="#sec-5" title="Methods" class="prev-section-link"><span>Previous Section</span></a><a href="#sec-15" title="Discussion" class="next-section-link"><span>Next Section</span></a></div>
                  
                  <h2>Results</h2>
                  
                  <p id="p-16">Of the 1918 abstracts identified initially, 50 full text articles were retrieved for detailed evaluation. All these studies
                     used a retrospective cohort design. Thirty-one articles were excluded (see <a id="xref-fig-2-1" class="xref-fig" href="#F2">Figure 2</a>) and 19 studies were included in the analysis. The kappa coefficient for agreement was 0.96. Data were available for OS at
                     both 3 and 5 years from 14 studies. For DFS, 10 studies provided data at 3 years, and 12 studies provided data at 5 years.
                  </p>
                  
                  <div id="F2" class="fig pos-float type-figure  odd">
                     <div class="fig-inline"><a href="djt319/F2.expansion.html"><img alt="Figure 2." src="djt319/F2.small.gif" /></a><div class="callout"><span>View larger version:</span><ul class="callout-links">
                              <li><a href="djt319/F2.expansion.html">In this window</a></li>
                              <li><a class="in-nw" href="djt319/F2.expansion.html">In a new window</a></li>
                           </ul>
                           <ul class="fig-services">
                              <li class="ppt-link"><a href="/powerpoint/106/1/djt319/F2">Download as PowerPoint Slide</a></li>
                           </ul>
                        </div>
                     </div>
                     <div class="fig-caption"><span class="fig-label">Figure 2.</span> 
                        
                        <p id="p-17" class="first-child">Flow diagram of included studies. AR = androgen receptor.</p>
                        
                        <div class="sb-div caption-clear"></div>
                     </div>
                  </div>
                  
                  <p id="p-18" class="indent">Characteristics of included studies are shown in <a id="xref-table-wrap-1-1" class="xref-table" href="#T1">Table 1</a>. The median and range of age between studies was representative of an early breast cancer, population with individual studies
                     reporting median age of between 49 and 61 years. There was heterogeneity in study populations; 15 studies (78.9%) included
                     women with both ER-positive and ER-negative breast cancer, two studies (10%) included only women with ER-expressing tumors,
                     and two studies (10.5%) included only women with ER-negative tumors. Definition of ER expression was reported in 13 studies
                     (68.4%). Among these, ER-positive disease was defined as 10% or greater staining in eight studies (42.1%), as greater than
                     5% staining in onee study (5.3%) and as 1% or greater staining in two studies (10.5%). Of the 7693 patients included in eligible
                     studies, 4658 patients (60.5%) had AR expression (AR-positive). Among ER-positive tumors, 74.8% also showed expression of
                     AR, where among ER-negative cancers, AR expression was seen in 31.8% of cases (χ<sup>2</sup>
                     <em>P</em> &lt; .001). Among PR-positive tumors, 77.0% showed expression of AR, but for PR-negative cancers, only 51.4% expressed AR (χ<sup>2</sup>
                     <em>P</em> &lt; .001). The association between AR and Ki-67 was explored in four studies (21.1%). All studies used a 10% cutoff to define
                     high Ki-67 expression. There was a highly statistically significant association between AR expression and low Ki-67 (χ<sup>2</sup>
                     <em>P</em> &lt; .001). There was no association between the presence of AR expression and tumor size (<em>P</em> = .12), nodal status (<em>P</em> = .78), tumor grade (<em>P=</em> .17), lymphovascular invasion (<em>P</em> = .19), or use of adjuvant chemotherapy (<em>P</em> = .12) or adjuvant endocrine treatment (<em>P</em> = .12).
                  </p>
                  
                  <div class="table pos-float" id="T1">
                     <div class="table-inline">
                        <div class="callout"><span>View this table:</span><ul class="callout-links">
                              <li><a href="djt319/T1.expansion.html">In this window</a></li>
                              <li><a class="in-nw" href="djt319/T1.expansion.html">In a new window</a></li>
                           </ul>
                        </div>
                     </div>
                     <div class="table-caption"><span class="table-label">Table 1.</span> 
                        
                        <p id="p-19" class="first-child">Characteristics of studies included in the meta-analysis*</p>
                        
                        <div class="sb-div caption-clear"></div>
                     </div>
                  </div>
                  
                  <p id="p-21" class="indent">Analysis of AR was carried out using immunohistochemistry (IHC) in 15 studies (78.9%), radioimmunoassay in three studies (15.8%),
                     and reverse-phase protein array in one study (5.3%). Among studies using IHC, positive results were determined as AR of 1%
                     or more of tumor cells in six studies (40.0%), 5% or more in one study (6.7%), 10% or more in six studies (40.0%), 75% or
                     more in one study (6.7%); this information was not reported in one study (6.7%).
                  </p>
                  
                  <div id="sec-12" class="subsection">
                     
                     <h3>Three-Year OS and DFS</h3>
                     
                     <p id="p-22">A total of 14 studies reported data for OS at 3-years. There was no evidence of statistically significant heterogeneity between
                        studies (Cochran’s <em>Q P</em> = 0.37, <em>I</em>
                        <sup>2</sup>=7%). Compared with tumors without AR expression, those with AR expression were associated with a statistically significant
                        improvement in OS (OR = 0.47; 95% CI = 0.39 to 0.58; <em>P</em> &lt; 0.001) (see <a id="xref-fig-3-1" class="xref-fig" href="#F3">Figure 3A</a>). This translated to an absolute difference in 3-year OS of 6.7% (95% CI = 3.5% to 9.8%). The association of AR expression
                        and improved 3-year OS appeared independent of coexpression of ER, with similar magnitudes of effect observed for studies
                        including only ER-positive patients (OR = 0.45; 95% CI = 0.29 to 0.69), those including only ER-negative patients (OR = 0.38;
                        95% CI = 0.13 to 1.10) and those with patients unselected for ER expression (OR = 0.47; 95% CI = 0.36 to 0.61). There was
                        no statistically significant difference between these subgroups (<em>P</em> = .93).
                     </p>
                     
                     <div id="F3" class="fig pos-float type-figure  odd">
                        <div class="fig-inline"><a href="djt319/F3.expansion.html"><img alt="Figure 3." src="djt319/F3.small.gif" /></a><div class="callout"><span>View larger version:</span><ul class="callout-links">
                                 <li><a href="djt319/F3.expansion.html">In this window</a></li>
                                 <li><a class="in-nw" href="djt319/F3.expansion.html">In a new window</a></li>
                              </ul>
                              <ul class="fig-services">
                                 <li class="ppt-link"><a href="/powerpoint/106/1/djt319/F3">Download as PowerPoint Slide</a></li>
                              </ul>
                           </div>
                        </div>
                        <div class="fig-caption"><span class="fig-label">Figure 3.</span> 
                           
                           <p id="p-23" class="first-child">Patient outcome at 3 years by androgen receptor (AR) expression<strong>. A</strong>) Three-year overall survival. <strong>B</strong>) Three-year disease-free survival. Odds ratios in reference to AR expression compared with no AR expression for each trial
                              are represented by the <strong>squares</strong>, the <strong>size of the square</strong> represents the weight of the trial in the meta-analysis, and the <strong>horizontal line</strong>  crossing the square represents the 95% confidence interval (CI). The <strong>diamonds</strong> represent the estimated pooled effect (labeled total). Estimates of odds ratios were weighted and pooled using the Mantel–Haenszel
                              random-effect model. Statistical heterogeneity was assessed using Cochran’s <em>Q</em> and <em>I</em>
                              <sup>2</sup> statistics. All <em>P</em> values are two-sided.
                           </p>
                           
                           <div class="sb-div caption-clear"></div>
                        </div>
                     </div>
                     
                     <p id="p-24" class="indent">A total of 10 studies reported data for DFS at 3 years. There was no evidence of statistically significant heterogeneity between
                        studies (Cochran’s <em>Q P</em> = 0.83; <em>I</em>
                        <sup>2</sup>=0%). Compared with tumors without AR expression, those with AR expression were associated with a statistically significant
                        improvement in DFS (OR = 0.43; 95% CI = 0.35 to 0.52; <em>P</em> &lt; .001) (see <a id="xref-fig-3-2" class="xref-fig" href="#F3">Figure 3B</a>). This translated to an absolute difference in 3-year DFS of 8.8% (95% CI = 5.2% to 12.3%). The association of AR expression
                        and improved 3-year DFS was similarly independent of coexpression of ER, with similar magnitudes of effect observed for studies
                        including only ER-positive patients (OR = 0.42; 95% CI = 0.31 to 0.57), those including only ER-negative patients (OR = 0.32;
                        95% CI = 0.15 to 0.70), and those with patients unselected for ER expression (OR = 0.40; 95% CI = 0.32 to 0.52). There was
                        no statistically significant difference between these subgroups (<em>P</em> = .83) (see <a id="xref-fig-4-1" class="xref-fig" href="#F4">Figure 4</a>).
                     </p>
                     
                     <div id="F4" class="fig pos-float type-figure  odd">
                        <div class="fig-inline"><a href="djt319/F4.expansion.html"><img alt="Figure 4." src="djt319/F4.small.gif" /></a><div class="callout"><span>View larger version:</span><ul class="callout-links">
                                 <li><a href="djt319/F4.expansion.html">In this window</a></li>
                                 <li><a class="in-nw" href="djt319/F4.expansion.html">In a new window</a></li>
                              </ul>
                              <ul class="fig-services">
                                 <li class="ppt-link"><a href="/powerpoint/106/1/djt319/F4">Download as PowerPoint Slide</a></li>
                              </ul>
                           </div>
                        </div>
                        <div class="fig-caption"><span class="fig-label">Figure 4.</span> 
                           
                           <p id="p-25" class="first-child">Three-year overall survival (OS) by androgen receptor (AR) expression based on coexpression of estrogen receptor (ER). Odds
                              ratios in reference to AR expression compared with no AR expression for each trial are represented by the <strong>squares</strong>, the <strong>size of the square</strong> represents the weight of the trial in the meta-analysis, and the <strong>horizontal line</strong> crossing the square represents the 95% confidence interval (CI). The <strong>diamonds</strong> represent the estimated pooled effect (labeled total). Estimates of odds ratios were weighted and pooled using the Mantel–Haenszel
                              random-effect model. Statistical heterogeneity was assessed using Cochran’s <em>Q</em> and <em>I</em>
                              <sup>2</sup> statistics. Test of subgroup differences relates to the test of heterogeneity between the three cohorts of ER expression
                              as defined by Deeks et al. (<a id="xref-ref-21-2" class="xref-bibr" href="#ref-21">21</a>). All <em>P</em> values are two-sided.
                           </p>
                           
                           <div class="sb-div caption-clear"></div>
                        </div>
                     </div>
                     
                  </div>
                  
                  <div id="sec-13" class="subsection">
                     
                     <h3>Five-Year OS and DFS</h3>
                     
                     <p id="p-26">A total of 14 studies reported data for OS at 5 years. There was statistically significant heterogeneity between studies (Cochran’s
                        <em>Q P</em> &lt; .001; <em>I</em>
                        <sup>2</sup> = 72%), which resulted from the inclusion of one study (<a id="xref-ref-22-2" class="xref-bibr" href="#ref-22">22</a>) with outlying data. Of interest, this study did not report the cutoff used for determination of AR expression, and we were
                        unable to retrieve this information from other sources. When all studies were included, there was a statistically significant
                        association between AR expression and improved 5-year OS compared with no AR expression (OR = 0.40; 95% CI = 0.29 to 0.56;
                        <em>P</em> &lt; .001) (see <a id="xref-fig-5-1" class="xref-fig" href="#F5">Figure 5A</a>). This translated to an absolute difference in 5-year OS of 13.5% (95% CI = 7.5% to 19.6%). Exclusion of the one study with
                        outlying data eliminated the heterogeneity (Cochran’s <em>Q P</em> = .57; <em>I</em>
                        <sup>2</sup> = 0%) but retained the statistically significant association between AR expression and improved 5-year OS compared with no
                        AR expression (OR = 0.51; 95% CI = 0.43 to 0.61; <em>P</em> &lt; .001).
                     </p>
                     
                     <div id="F5" class="fig pos-float type-figure  odd">
                        <div class="fig-inline"><a href="djt319/F5.expansion.html"><img alt="Figure 5." src="djt319/F5.small.gif" /></a><div class="callout"><span>View larger version:</span><ul class="callout-links">
                                 <li><a href="djt319/F5.expansion.html">In this window</a></li>
                                 <li><a class="in-nw" href="djt319/F5.expansion.html">In a new window</a></li>
                              </ul>
                              <ul class="fig-services">
                                 <li class="ppt-link"><a href="/powerpoint/106/1/djt319/F5">Download as PowerPoint Slide</a></li>
                              </ul>
                           </div>
                        </div>
                        <div class="fig-caption"><span class="fig-label">Figure 5.</span> 
                           
                           <p id="p-27" class="first-child">Five-year patient outcome by androgen receptor (AR) expression<strong>. A)</strong> Five-year overall survival. <strong>B</strong>) Five-year disease-free survival. Odds ratios in reference to AR expression compared with no AR expression for each trial
                              are represented by the <strong>squares</strong>, the <strong>size of the square</strong> represents the weight of the trial in the meta-analysis, and the <strong>horizontal line</strong> crossing the square represents the 95% confidence interval. The <strong>diamonds</strong> represent the estimated pooled effect (labeled total). Estimates of odds ratios were weighted and pooled using the Mantel–Haenszel
                              random-effect model. Statistical heterogeneity was assessed using Cochran’s <em>Q</em> and <em>I</em>
                              <sup>2</sup> statistics. All <em>P</em> values are two-sided.
                           </p>
                           
                           <div class="sb-div caption-clear"></div>
                        </div>
                     </div>
                     
                     <p id="p-28" class="indent">Similar to the 3-year OS data, the association between AR expression and improved 5-year OS was also independent of coexpression
                        of ER, with similar magnitudes of effect observed for studies including only ER-positive patients (OR = 0.49; 95% CI = 0.36
                        to 0.66), those including only ER-negative patients (OR = 0.59; 95% CI = 0.28 to 1.25), and those with patients unselected
                        for ER expression (OR = 0.39; 95% CI = 0.19 to 0.83). There was no statistically significant difference between these subgroups
                        (<em>P</em> = .75).
                     </p>
                     
                     <p id="p-29" class="indent">A total of 12 studies reported data for DFS at 5-years. There was again evidence of statistically significant heterogeneity
                        between studies (Cochran’s <em>Q P</em> &lt; .001; <em>I</em>
                        <sup>2</sup>=91%). This resulted from general interstudy heterogeneity without evidence that this was a consequence of inclusion of studies
                        with outlying data. Compared with tumors without AR expression, those with AR expression were associated with a statistically
                        significant improvement in DFS (OR = 0.34; 95% CI = 0.21 to 0.56; <em>P</em> &lt; .001) (see <a id="xref-fig-5-2" class="xref-fig" href="#F5">Figure 5B</a>). This translated to an absolute difference in 5-year DFS of 20.7% (95% CI = 8.7% to 32.7%). The association of AR expression
                        and improved 5-year DFS was once again independent of coexpression of ER, with similar magnitudes of effect observed for studies
                        including only ER-positive patients (OR = 0.41; 95% CI = 0.20 to 0.83), those including only ER-negative patients (OR = 0.39;
                        95% CI = 0.13 to 1.16), and those with patients unselected for ER expression (OR = 0.27; 95% CI = 0.11 to 0.71). There was
                        no statistically significant difference between these subgroups (<em>P</em> = .79).
                     </p>
                     
                  </div>
                  
                  <div id="sec-14" class="subsection">
                     
                     <h3>Sensitivity Analyses</h3>
                     
                     <p id="p-30">Removal of studies using radioimmunoassay or reverse-phase protein array did not influence results for 3-year or 5-year OS
                        (OR = 0.43, 95% CI = 0.31 to 0.60; OR = 0.37, 95% CI = 0.25 to 0.55, respectively). Similarly, removal of the single study
                        (<a id="xref-ref-13-3" class="xref-bibr" href="#ref-13">13</a>) that was an outlier with regard to definition of AR expression by IHC (75% vs 1%–10% for other studies) did not substantially
                        affect the association between AR expression and favorable 3-year and 5-year OS compared with no AR expression (OR = 0.48,
                        95% CI = 0.36 to 0.62; OR = 0.36, 95% CI = 0.23 to 0.55, respectively). Exclusion of these studies did not reduce heterogeneity
                        for 5-year OS (Cochran’s <em>Q P</em> &lt; .001, <em>I</em>
                        <sup>2</sup> = 75%; Cochran’s <em>Q P</em> &lt; .001, <em>I</em>
                        <sup>2</sup> = 77%, respectively).
                     </p>
                     
                     <p id="p-31" class="indent">Among studies using IHC, use of different cutoffs for AR overexpression was not statistically different; the association between
                        AR overexpression and outcome was similar for both the 1% and 10% thresholds, and the test for subgroup difference did not
                        meet statistical significance for either 3-year or 5-year OS <em>(P =</em> .62 and <em>P =</em> .09, respectively). Similarly, use of difference cutoffs for ER expression was not associated with a statistically significant
                        test for subgroup difference for either 3-year or 5-year OS (<em>P</em> = .51 and <em>P</em> = .32, respectively).
                     </p>
                     
                     <p id="p-32" class="indent">Corresponding authors of papers using the IHC cutoff of ≥10% for AR positivity were contacted to retrieve any available data
                        using the ≥1% cutoff. Responses were received from three authors (<a id="xref-ref-4-2" class="xref-bibr" href="#ref-4">4</a>,<a id="xref-ref-23-2" class="xref-bibr" href="#ref-23">23</a>,<a id="xref-ref-24-2" class="xref-bibr" href="#ref-24">24</a>). For one study, 5% of the study cohort had AR expression between 1% and 9%, increasing the proportion of patients considered
                        positive from 58% to 63% (Byeong-Woo Park and Seho Park, personal communication). Using the 1% rather than 10% cutoff for
                        AR led to marginally different values of median OS and DFS but did not change the statistical significance. Of the two other
                        authors who responded, one did not have any further information available (Rong Hu, personal communication), and another described
                        that the association between AR and outcome was smaller, but was unable to provide updated data (Naoko Honma, personal communication).
                     </p>
                     
                     <p id="p-33" class="indent">Among studies using IHC, there did not appear to be any difference between those where assessment was made using nuclear compared
                        with nonnuclear staining. The odds ratios for 3-year OS for nuclear vs nonnuclear assessment were 0.42 (95% CI = 0.30 to 0.59)
                        and 0.17 (95% CI = 0.02 to 1.55), and the test for subgroup difference was 0.43. Similar data were seen for 5-year OS (OR
                        = 0.55, 95% CI = 0.44 to 0.70 vs OR = 0.35, 95% CI = 0.19 to 0.62; subgroup difference <em>P =</em> .14).
                     </p>
                     
                     <p id="p-34" class="indent">Although the definition of early vs metastatic breast cancer has been relatively standard over time, between 1987 and 2002,
                        patients with supraclavicular nodal metastases at diagnosis of breast cancer were classified as having metastatic disease
                        (<a id="xref-ref-25-1" class="xref-bibr" href="#ref-25">25</a>). Before and after this time, these patients were considered to have early breast cancer. Exclusion of studies published
                        during this time did not affect the association between AR-expression with either 3-year or 5-year OS (OR = 0.46, 95% CI =
                        0.36 to 0.58; OR = 0.38, 95% CI = 0.27 to 0.54, respectively). Furthermore, there was no apparent improvement in heterogeneity
                        for 5-year OS (Cochran’s <em>Q P</em> &lt; .001; <em>I</em>
                        <sup>2</sup> = 73%).
                     </p>
                     
                     <p id="p-35" class="indent">Only two studies, which involved a total of 78 patients, reported the influence of AR expression in HER2/neu-positive breast
                        cancer. In these studies, there was no statistically significant effect of AR expression for either OS or DFS (OR = 1.58,
                        95% CI = 0.09 to 27.26, <em>P =</em> .75; OR = 0.92, 95% CI = 0.34 to 2.52, <em>P =</em> 0.87, respectively). As a consequence of this very small sample size, a meaningful analysis of the role of AR on outcome
                        in women with HER2/neu-positive breast cancer was not possible.
                     </p>
                     
                  </div>
                  
               </div>
               <div class="section" id="sec-15">
                  <div class="section-nav"><a href="#sec-11" title="Results" class="prev-section-link"><span>Previous Section</span></a><a href="#sec-16" title="Funding" class="next-section-link"><span>Next Section</span></a></div>
                  
                  <h2>Discussion</h2>
                  
                  <p id="p-36">Various studies have attempted to describe the association of AR expression and outcome in early breast cancer. However, there
                     remain unanswered questions about the direction and magnitude of effect of AR on outcome and whether the outcome is consistent
                     among different subgroups. Here, we report a systematic review of 7693 patients included in 19 different studies. Our review
                     shows that the expression of AR is a marker of good prognosis, with approximately a doubling of OS at 3 and 5 years. This
                     effect appeared independent of coexpression of ER.
                  </p>
                  
                  <p id="p-37" class="indent">Based on preclinical findings of the effects promoted by the AR in breast cancer cell lines, we hypothesized better outcomes
                     in women with tumors expressing both ER and AR compared with those expressing ER but not AR. Results of this review support
                     this hypothesis. Preclinical data for ER-negative/AR-positive breast cancer suggest a poor prognosis, but the results of this
                     review refute this. This finding may be explained by the association of AR with low proliferative activity as measured by
                     Ki67 expression (<a id="xref-ref-26-1" class="xref-bibr" href="#ref-26">26</a>).
                  </p>
                  
                  <p id="p-38" class="indent">Among HER2-overexpressing breast tumors, AR can be highly expressed (<a id="xref-ref-18-3" class="xref-bibr" href="#ref-18">18</a>). AR expression appears more frequently in ER-negative and HER2-overexpressing tumors compared with those that also express
                     ER (<a id="xref-ref-27-1" class="xref-bibr" href="#ref-27">27</a>). An interaction between AR and HER2 has been suggested (<a id="xref-ref-28-1" class="xref-bibr" href="#ref-28">28</a>). In this analysis, there were too few women with HER2-overexpressing tumors to definitively evaluate any association between
                     AR expression and outcome in women with HER2/neu-positive breast cancer.
                  </p>
                  
                  <p id="p-39" class="indent">Our results are of clinical relevance in view of the emergence of new drugs targeting AR. Despite an association with good
                     outcome, targeting of breast tumors expressing AR may be beneficial, similar to the effects of pharmacologic targeting of
                     ER. Bicalutamide, a nonsteroidal antiandrogen, has been evaluated in metastatic breast cancer in a multicenter phase II trial
                     of women with ER-negative/PR-negative breast cancer (&lt;10% by IHC) and AR expression (&gt;10% by IHC); 26 patients were treated
                     with bicalutamide, and 21 were evaluated for response. Of these, 19% achieved complete or partial response or stable disease
                     for longer than 6 months (<a id="xref-ref-5-1" class="xref-bibr" href="#ref-5">5</a>). These data warrant further investigation.
                  </p>
                  
                  <p id="p-40" class="indent">In women with ER-positive metastatic breast cancer, treatment with sequential lines of endocrine therapy (eg, tamoxifen, aromatase
                     inhibitors, or fulvestrant) leads to development of resistance to ER-targeted therapy (<a id="xref-ref-29-1" class="xref-bibr" href="#ref-29">29</a>). Numerous mechanisms explaining this resistance have been suggested, including cross-talk with or increased expression of
                     components of growth receptor pathways, especially those belonging to the epidermal growth factor superfamily or to insulin
                     growth factor receptors. Other postulated mechanism include aberrant activation of other growth factor signaling pathways,
                     overexpression of myc, cycline E1, and cycline D1, epigenetic modification, as well as mutations, deletions, and truncations
                     in the <em>ERα</em> gene (<a id="xref-ref-30-1" class="xref-bibr" href="#ref-30">30–35</a>). In the presence of a nonfunctional ER, AR may be the primary driver of downstream signaling for cell growth (<a id="xref-ref-36-1" class="xref-bibr" href="#ref-36">36</a>). Pharmacological antagonism of AR has potential to reverse this signaling (<a id="xref-ref-36-2" class="xref-bibr" href="#ref-36">36</a>). Two novel agents, enzalutamide, an irreversible inhibitor of AR-dependent signaling, and abiraterone, an inhibitor of the
                     17 α-hydroxylase/C17,20 lyase that inhibits synthesis of androgens, have become available for treatment of prostate cancer
                     (<a id="xref-ref-37-1" class="xref-bibr" href="#ref-37">37</a>,<a id="xref-ref-38-1" class="xref-bibr" href="#ref-38">38</a>) and may have activity against breast cancer. Abiraterone, by inhibiting formation of adrenal androgens, may also lead to
                     a reduction in circulating estrogens in postmenopusal women by reducing the substrate for aromatase. Cancer Research UK is
                     conducting a trial of abiraterone acetate in postmenopausal women with advanced or metastatic breast cancer. This phase I/II
                     open-label study is evaluating the safety, endocrine effects, and antitumor activity in patients with ER- and AR-expressing
                     tumors (<a href="/external-ref?link_type=CLINTRIALGOV&amp;access_num=NCT00755885">NCT00755885</a>) (<a id="xref-ref-39-1" class="xref-bibr" href="#ref-39">39</a>). A further industry-sponsored multicenter study is evaluating the efficacy of abiraterone and prednisone with or without
                     exemestane in postmenopausal women with ER-positive metastatic breast cancer after progression on nonsteroidal aromatase inhibitor
                     therapy, regardless of AR expression (<a href="/external-ref?link_type=CLINTRIALGOV&amp;access_num=NCT01381874">NCT01381874</a>) (<a id="xref-ref-40-1" class="xref-bibr" href="#ref-40">40</a>).
                  </p>
                  
                  <p id="p-41" class="indent">There are several limitations of our study. First, this is a systematic review and meta-analysis of the literature, and therefore,
                     we were only able to extract population-level rather than individual patient–level data. This reduced our ability to test
                     for associations between variables in specific subgroups and also limited our ability to assess for sources of heterogeneity.
                     Second, there was marked heterogeneity in patient populations, methods for assessing AR, definition of AR positivity, and
                     follow-up of patients. For 5-year OS, the interstudy heterogeneity in effect size was influenced by a single outlying study,
                     but for 5-year DFS, no clear source for heterogeneity was identified. Random-effects modeling and sensitivity analyses were
                     conducted to address this heterogeneity, but these statistical methods may not be sufficient, and there is uncertainty about
                     the accuracy of our 5-year DFS results. Finally, data on OS and DFS were extracted from text, figures, and tables of articles.
                     We were unable to extract or model hazard ratios, so we have reported odds ratios for OS and DFS instead. Odds ratios provide
                     a less robust measure of time to event outcomes because they do not take into account the time to an event of interest, but
                     it was the only feasible method with the data available.
                  </p>
                  
                  <p id="p-42" class="indent">In conclusion, AR expression appears to be associated with improved OS and DFS regardless of ER expression. In view of the
                     prognostic significance of AR, its association with activity of androgen therapy, and initial clinical data showing biologic
                     activity of targeting of AR, further studies evaluating therapeutic targeting of AR are warranted. The selection of ER-negative
                     and AR-positive patients, as well as ER-positive and AR-positive patients who have developed endocrine resistance, would likely
                     enrich for patients with activated AR-related pathways.
                  </p>
                  
               </div>
               <div class="section" id="sec-16">
                  <div class="section-nav"><a href="#sec-15" title="Discussion" class="prev-section-link"><span>Previous Section</span></a><a href="#notes-1" title="Notes" class="next-section-link"><span>Next Section</span></a></div>
                  
                  <h2>Funding</h2>
                  
                  <p id="p-43">This Work was supported by funding from <span class="funding-source">Consejo Nacional de Ciencia y Tecnologia, Mexico</span> (<span class="award-id" id="award-id-1">214638</span> to FEV-B).
                  </p>
                  
               </div>
               <div class="section notes" id="notes-1">
                  <div class="section-nav"><a href="#sec-16" title="Funding" class="prev-section-link"><span>Previous Section</span></a><a href="#ref-list-1" title="References" class="next-section-link"><span>Next Section</span></a></div>
                  <h2>Notes</h2>
                  
                  <p id="p-44">The study sponsor had no role in the design of the study; the collection, analysis, and interpretation of the data; the writing
                     of the manuscript; and the decision to submit the manuscript for publication.
                  </p>
                  
                  <p id="p-45">I. Diaz-Padilla holds an employee position with Novartis AG; however, this meta-analysis was written before he commenced this
                     appointment.
                  </p>
                  
               </div>
               <ul class="copyright-statement">
                  <li class="fn" id="copyright-statement-1">© The Author 2013. Published by Oxford University Press. All rights reserved. For Permissions, please e-mail: journals.permissions@oup.com.</li>
               </ul>
               <div class="section ref-list" id="ref-list-1">
                  <div class="section-nav"><a href="#notes-1" title="Notes" class="prev-section-link"><span>Previous Section</span></a><div class="nav-placeholder"> </div>
                  </div>
                  <h2>References</h2>
                  <ol class="cit-list ref-use-labels">
                     <li><span class="ref-label">1.</span><a class="rev-xref-ref" href="#xref-ref-1-1" title="View reference 1. in text"
                           id="ref-1">↵</a>
                        
                        
                        <div class="cit ref-cit ref-journal" id="cit-106.1.djt319.1"
                             data-doi="10.1002/1097-0142(19810201)47:3&lt;554::AID-CNCR2820470322&gt;3.0.CO;2-W">
                           <div class="cit-metadata">
                              <ol class="cit-auth-list">
                                 <li><span class="cit-auth"><span class="cit-name-surname">Samaan</span>  <span class="cit-name-given-names">NA</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Buzdar</span>  <span class="cit-name-given-names">AU</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Aldinger</span>  <span class="cit-name-given-names">KA</span></span>, 
                                 </li>
                                 <li><span class="cit-etal">et al.</span></li>
                              </ol><cite>
                                 <span class="cit-article-title">Estrogen receptor: a prognostic factor in breast cancer</span>. <abbr class="cit-jnl-abbrev">Cancer</abbr>. <span class="cit-pub-date">1981</span>;<span class="cit-vol">47</span>(<span class="cit-issue">3</span>):<span class="cit-fpage">554</span>–<span class="cit-lpage">560</span>.</cite></div>
                           <div class="cit-extra"><a href="/external-ref?access_num=10.1002/1097-0142(19810201)47:3%3C554::AID-CNCR2820470322%3E3.0.CO;2-W&amp;link_type=DOI"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-webofscience">CrossRef</a><a href="/external-ref?access_num=7226005&amp;link_type=MED"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-medline">Medline</a><a href="/external-ref?access_num=A1981LB36100021&amp;link_type=ISI"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-webofscience">Web of Science</a><a target="_blank"
                                 href="http://scholar.google.com/scholar_lookup?title=Estrogen%20receptor%3A%20a%20prognostic%20factor%20in%20breast%20cancer&amp;author=NA%20Samaan&amp;author=AU%20Buzdar&amp;author=KA%20Aldinger&amp;publication_year=1981&amp;journal=Cancer&amp;volume=47&amp;issue=3&amp;pages=554-560">Google Scholar</a></div>
                        </div>
                        
                     </li>
                     <li><span class="ref-label">2.</span><a class="rev-xref-ref" href="#xref-ref-2-1" title="View reference 2. in text"
                           id="ref-2">↵</a>
                        
                        
                        <div class="cit ref-cit ref-journal" id="cit-106.1.djt319.2"
                             data-doi="10.1001/jama.295.21.2492">
                           <div class="cit-metadata">
                              <ol class="cit-auth-list">
                                 <li><span class="cit-auth"><span class="cit-name-surname">Carey</span>  <span class="cit-name-given-names">LA</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Perou</span>  <span class="cit-name-given-names">CM</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Livasy</span>  <span class="cit-name-given-names">CA</span></span>, 
                                 </li>
                                 <li><span class="cit-etal">et al.</span></li>
                              </ol><cite>
                                 <span class="cit-article-title">Race, breast cancer subtypes, and survival in the Carolina Breast Cancer Study</span>. <abbr class="cit-jnl-abbrev">JAMA</abbr>. <span class="cit-pub-date">2006</span>;<span class="cit-vol">295</span>(<span class="cit-issue">21</span>):<span class="cit-fpage">2492</span>–<span class="cit-lpage">2502</span>.</cite></div>
                           <div class="cit-extra"><a href="/external-ref?access_num=10.1001/jama.295.21.2492&amp;link_type=DOI"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-webofscience">CrossRef</a><a href="/external-ref?access_num=16757721&amp;link_type=MED"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-medline">Medline</a><a href="/external-ref?access_num=000238057300024&amp;link_type=ISI"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-webofscience">Web of Science</a><a target="_blank"
                                 href="http://scholar.google.com/scholar_lookup?title=Race%2C%20breast%20cancer%20subtypes%2C%20and%20survival%20in%20the%20Carolina%20Breast%20Cancer%20Study&amp;author=LA%20Carey&amp;author=CM%20Perou&amp;author=CA%20Livasy&amp;publication_year=2006&amp;journal=JAMA&amp;volume=295&amp;issue=21&amp;pages=2492-2502">Google Scholar</a></div>
                        </div>
                        
                     </li>
                     <li><span class="ref-label">3.</span><a class="rev-xref-ref" href="#xref-ref-3-1" title="View reference 3. in text"
                           id="ref-3">↵</a>
                        
                        
                        <div class="cit ref-cit ref-journal" id="cit-106.1.djt319.3"
                             data-doi="10.1007/s00428-006-0213-6">
                           <div class="cit-metadata">
                              <ol class="cit-auth-list">
                                 <li><span class="cit-auth"><span class="cit-name-surname">Schippinger</span>  <span class="cit-name-given-names">W</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Regitnig</span>  <span class="cit-name-given-names">P</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Dandachi</span>  <span class="cit-name-given-names">N</span></span>, 
                                 </li>
                                 <li><span class="cit-etal">et al.</span></li>
                              </ol><cite>
                                 <span class="cit-article-title">Evaluation of the prognostic significance of androgen receptor expression in metastatic breast cancer</span>. <abbr class="cit-jnl-abbrev">Virchows Arch</abbr>. <span class="cit-pub-date">2006</span>;<span class="cit-vol">449</span>(<span class="cit-issue">1</span>):<span class="cit-fpage">24</span>–<span class="cit-lpage">30</span>.</cite></div>
                           <div class="cit-extra"><a href="/external-ref?access_num=10.1007/s00428-006-0213-6&amp;link_type=DOI"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-webofscience">CrossRef</a><a href="/external-ref?access_num=16628414&amp;link_type=MED"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-medline">Medline</a><a href="/external-ref?access_num=000238671000003&amp;link_type=ISI"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-webofscience">Web of Science</a><a target="_blank"
                                 href="http://scholar.google.com/scholar_lookup?title=Evaluation%20of%20the%20prognostic%20significance%20of%20androgen%20receptor%20expression%20in%20metastatic%20breast%20cancer&amp;author=W%20Schippinger&amp;author=P%20Regitnig&amp;author=N%20Dandachi&amp;publication_year=2006&amp;journal=Virchows%20Arch&amp;volume=449&amp;issue=1&amp;pages=24-30">Google Scholar</a></div>
                        </div>
                        
                     </li>
                     <li><span class="ref-label">4.</span><a class="rev-xref-ref" href="#xref-ref-4-2" title="View reference 4. in text"
                           id="ref-4">↵</a>
                        
                        
                        <div class="cit ref-cit ref-journal" id="cit-106.1.djt319.4"
                             data-doi="10.1158/1078-0432.CCR-10-2021">
                           <div class="cit-metadata">
                              <ol class="cit-auth-list">
                                 <li><span class="cit-auth"><span class="cit-name-surname">Hu</span>  <span class="cit-name-given-names">R</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Dawood</span>  <span class="cit-name-given-names">S</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Holmes</span>  <span class="cit-name-given-names">MD</span></span>, 
                                 </li>
                                 <li><span class="cit-etal">et al.</span></li>
                              </ol><cite>
                                 <span class="cit-article-title">Androgen receptor expression and breast cancer survival in postmenopausal women</span>. <abbr class="cit-jnl-abbrev">Clin Cancer Res</abbr>. <span class="cit-pub-date">2011</span>;<span class="cit-vol">17</span>(<span class="cit-issue">7</span>):<span class="cit-fpage">1867</span>–<span class="cit-lpage">1874</span>.</cite></div>
                           <div class="cit-extra"><a href="/cgi/ijlink?linkType=ABST&amp;journalCode=clincanres&amp;resid=17/7/1867"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-ijlinks"><span class="cit-reflinks-abstract">Abstract</span><span class="cit-sep cit-reflinks-variant-name-sep">/</span><span class="cit-reflinks-full-text"><span class="free-full-text">FREE </span>Full Text</span></a></div>
                        </div>
                        
                     </li>
                     <li><span class="ref-label">5.</span><a class="rev-xref-ref" href="#xref-ref-5-1" title="View reference 5. in text"
                           id="ref-5">↵</a>
                        
                        
                        <div class="cit ref-cit ref-journal" id="cit-106.1.djt319.5">
                           <div class="cit-metadata">
                              <ol class="cit-auth-list">
                                 <li><span class="cit-auth"><span class="cit-name-surname">Gucalp</span>  <span class="cit-name-given-names">A</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Tolaney</span>  <span class="cit-name-given-names">S</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Isakoff</span>  <span class="cit-name-given-names">S</span></span>, 
                                 </li>
                                 <li><span class="cit-etal">et al.</span></li>
                              </ol><cite>
                                 <span class="cit-article-title">Targeting the androgen receptor (AR) in women with AR+ ER-/PR- metastatic breast cancer (MBC)</span>. <abbr class="cit-jnl-abbrev">J Clin Oncol</abbr>. <span class="cit-pub-date">2012</span>;<span class="cit-vol">30</span>(<span class="cit-supplement">Suppl</span>):abstract 1006.</cite></div>
                           <div class="cit-extra"><a target="_blank"
                                 href="http://scholar.google.com/scholar_lookup?title=Targeting%20the%20androgen%20receptor%20%28AR%29%20in%20women%20with%20AR%2B%20ER-%2FPR-%20metastatic%20breast%20cancer%20%28MBC%29&amp;author=A%20Gucalp&amp;author=S%20Tolaney&amp;author=S%20Isakoff&amp;publication_year=2012&amp;journal=J%20Clin%20Oncol&amp;volume=30">Google Scholar</a></div>
                        </div>
                        
                     </li>
                     <li><span class="ref-label">6.</span><a class="rev-xref-ref" href="#xref-ref-6-1" title="View reference 6. in text"
                           id="ref-6">↵</a>
                        
                        
                        <div class="cit ref-cit ref-journal" id="cit-106.1.djt319.6"
                             data-doi="10.1056/NEJM195810022591404">
                           <div class="cit-metadata">
                              <ol class="cit-auth-list">
                                 <li><span class="cit-auth"><span class="cit-name-surname">Kennedy</span>  <span class="cit-name-given-names">BJ</span></span></li>
                              </ol><cite>. <span class="cit-article-title">Fluoxymesterone therapy in advanced breast cancer</span>. <abbr class="cit-jnl-abbrev">N Engl J Med</abbr>. <span class="cit-pub-date">1958</span>;<span class="cit-vol">259</span>(<span class="cit-issue">14</span>):<span class="cit-fpage">673</span>–<span class="cit-lpage">675</span>.</cite></div>
                           <div class="cit-extra"><a href="/external-ref?access_num=10.1056/NEJM195810022591404&amp;link_type=DOI"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-webofscience">CrossRef</a><a href="/external-ref?access_num=13590423&amp;link_type=MED"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-medline">Medline</a><a target="_blank"
                                 href="http://scholar.google.com/scholar_lookup?title=Fluoxymesterone%20therapy%20in%20advanced%20breast%20cancer&amp;author=BJ%20Kennedy&amp;publication_year=1958&amp;journal=N%20Engl%20J%20Med&amp;volume=259&amp;issue=14&amp;pages=673-675">Google Scholar</a></div>
                        </div>
                        
                     </li>
                     <li><span class="ref-label">7.</span>
                        
                        
                        <div class="cit ref-cit ref-journal no-rev-xref" id="cit-106.1.djt319.7">
                           <div class="cit-metadata">
                              <ol class="cit-auth-list">
                                 <li><span class="cit-auth"><span class="cit-name-surname">Stoll</span>  <span class="cit-name-given-names">BA</span></span></li>
                              </ol><cite>. <span class="cit-article-title">Fluoxymesterone (halotestin) in advanced breast carcinoma</span>. <abbr class="cit-jnl-abbrev">Med J Aust</abbr>. <span class="cit-pub-date">1959</span>;<span class="cit-vol">46</span>(<span class="cit-issue">3</span>):<span class="cit-fpage">70</span>–<span class="cit-lpage">74</span>.</cite></div>
                           <div class="cit-extra"><a href="/external-ref?access_num=13621861&amp;link_type=MED"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-medline">Medline</a><a target="_blank"
                                 href="http://scholar.google.com/scholar_lookup?title=Fluoxymesterone%20%28halotestin%29%20in%20advanced%20breast%20carcinoma&amp;author=BA%20Stoll&amp;publication_year=1959&amp;journal=Med%20J%20Aust&amp;volume=46&amp;issue=3&amp;pages=70-74">Google Scholar</a></div>
                        </div>
                        
                     </li>
                     <li><span class="ref-label">8.</span>
                        
                        
                        <div class="cit ref-cit ref-journal no-rev-xref" id="cit-106.1.djt319.8">
                           <div class="cit-metadata">
                              <ol class="cit-auth-list">
                                 <li><span class="cit-auth"><span class="cit-name-surname">Beckett</span>  <span class="cit-name-given-names">VL</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Brennan</span>  <span class="cit-name-given-names">MJ</span></span></li>
                              </ol><cite>. <span class="cit-article-title">Treatment of advanced breast cancer with fluoxymesterone (halotestin)</span>. <abbr class="cit-jnl-abbrev">Surg Gynecol Obstet</abbr>. <span class="cit-pub-date">1959</span>;<span class="cit-vol">109</span>(<span class="cit-issue">2</span>):<span class="cit-fpage">235</span>–<span class="cit-lpage">239</span>.</cite></div>
                           <div class="cit-extra"><a href="/external-ref?access_num=13675999&amp;link_type=MED"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-medline">Medline</a><a target="_blank"
                                 href="http://scholar.google.com/scholar_lookup?title=Treatment%20of%20advanced%20breast%20cancer%20with%20fluoxymesterone%20%28halotestin%29&amp;author=VL%20Beckett&amp;author=MJ%20Brennan&amp;publication_year=1959&amp;journal=Surg%20Gynecol%20Obstet&amp;volume=109&amp;issue=2&amp;pages=235-239">Google Scholar</a></div>
                        </div>
                        
                     </li>
                     <li><span class="ref-label">9.</span>
                        
                        
                        <div class="cit ref-cit ref-journal no-rev-xref" id="cit-106.1.djt319.9"
                             data-doi="10.1001/archinte.1961.03620020091008">
                           <div class="cit-metadata">
                              <ol class="cit-auth-list">
                                 <li><span class="cit-auth"><span class="cit-name-surname">Lowe</span>  <span class="cit-name-given-names">R</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">De Lorimier</span>  <span class="cit-name-given-names">AA</span>  <span class="cit-name-suffix">Jr</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Gordan</span>  <span class="cit-name-given-names">GS</span></span>, 
                                 </li>
                                 <li><span class="cit-etal">et al.</span></li>
                              </ol><cite>
                                 <span class="cit-article-title">Antitumor efficacy of fluoxymesterone. Use in advanced breast cancer</span>. <abbr class="cit-jnl-abbrev">Arch Intern Med</abbr>. <span class="cit-pub-date">1961</span>;<span class="cit-vol">107</span>:<span class="cit-fpage">241</span>–<span class="cit-lpage">244</span>.</cite></div>
                           <div class="cit-extra"><a href="/external-ref?access_num=10.1001/archinte.1961.03620020091008&amp;link_type=DOI"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-webofscience">CrossRef</a><a href="/external-ref?access_num=13763814&amp;link_type=MED"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-medline">Medline</a><a href="/external-ref?access_num=A19615555A00008&amp;link_type=ISI"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-webofscience">Web of Science</a><a target="_blank"
                                 href="http://scholar.google.com/scholar_lookup?title=Antitumor%20efficacy%20of%20fluoxymesterone.%20Use%20in%20advanced%20breast%20cancer&amp;author=R%20Lowe&amp;author=AA%20De%20Lorimier&amp;author=GS%20Gordan&amp;publication_year=1961&amp;journal=Arch%20Intern%20Med&amp;volume=107&amp;pages=241-244">Google Scholar</a></div>
                        </div>
                        
                     </li>
                     <li><span class="ref-label">10.</span><a class="rev-xref-ref" href="#xref-ref-10-1" title="View reference 10. in text"
                           id="ref-10">↵</a>
                        
                        
                        <div class="cit ref-cit ref-journal" id="cit-106.1.djt319.10"
                             data-doi="10.1007/s10549-005-9152-1">
                           <div class="cit-metadata">
                              <ol class="cit-auth-list">
                                 <li><span class="cit-auth"><span class="cit-name-surname">Ingle</span>  <span class="cit-name-given-names">JN</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Suman</span>  <span class="cit-name-given-names">VJ</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Mailliard</span>  <span class="cit-name-given-names">JA</span></span>, 
                                 </li>
                                 <li><span class="cit-etal">et al.</span></li>
                              </ol><cite>
                                 <span class="cit-article-title">Randomized trial of tamoxifen alone or combined with fluoxymesterone as adjuvant therapy in postmenopausal women with resected
                                    estrogen receptor positive breast cancer. North Central Cancer Treatment Group Trial 89-30-52</span>. <abbr class="cit-jnl-abbrev">Breast Cancer Res Treat</abbr>. <span class="cit-pub-date">2006</span>;<span class="cit-vol">98</span>(<span class="cit-issue">2</span>):<span class="cit-fpage">217</span>–<span class="cit-lpage">222</span>.</cite></div>
                           <div class="cit-extra"><a href="/external-ref?access_num=10.1007/s10549-005-9152-1&amp;link_type=DOI"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-webofscience">CrossRef</a><a href="/external-ref?access_num=16538529&amp;link_type=MED"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-medline">Medline</a><a href="/external-ref?access_num=000239593700013&amp;link_type=ISI"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-webofscience">Web of Science</a><a target="_blank"
                                 href="http://scholar.google.com/scholar_lookup?title=Randomized%20trial%20of%20tamoxifen%20alone%20or%20combined%20with%20fluoxymesterone%20as%20adjuvant%20therapy%20in%20postmenopausal%20women%20with%20resected%20estrogen%20receptor%20positive%20breast%20cancer.%20North%20Central%20Cancer%20Treatment%20Group%20Trial%2089-30-52&amp;author=JN%20Ingle&amp;author=VJ%20Suman&amp;author=JA%20Mailliard&amp;publication_year=2006&amp;journal=Breast%20Cancer%20Res%20Treat&amp;volume=98&amp;issue=2&amp;pages=217-222">Google Scholar</a></div>
                        </div>
                        
                     </li>
                     <li><span class="ref-label">11.</span><a class="rev-xref-ref" href="#xref-ref-11-1" title="View reference 11. in text"
                           id="ref-11">↵</a>
                        
                        
                        <div class="cit ref-cit ref-journal" id="cit-106.1.djt319.11">
                           <div class="cit-metadata">
                              <ol class="cit-auth-list">
                                 <li><span class="cit-auth"><span class="cit-name-surname">Ingle</span>  <span class="cit-name-given-names">JN</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Twito</span>  <span class="cit-name-given-names">DI</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Schaid</span>  <span class="cit-name-given-names">DJ</span></span>, 
                                 </li>
                                 <li><span class="cit-etal">et al.</span></li>
                              </ol><cite>
                                 <span class="cit-article-title">Randomized clinical trial of tamoxifen alone or combined with fluoxymesterone in postmenopausal women with metastatic breast
                                    cancer</span>. <abbr class="cit-jnl-abbrev">J Clin Oncol</abbr>. <span class="cit-pub-date">1988</span>;<span class="cit-vol">6</span>(<span class="cit-issue">5</span>):<span class="cit-fpage">825</span>–<span class="cit-lpage">831</span>.</cite></div>
                           <div class="cit-extra"><a href="/cgi/ijlink?linkType=ABST&amp;journalCode=jco&amp;resid=6/5/825"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-ijlinks"><span class="cit-reflinks-abstract">Abstract</span><span class="cit-sep cit-reflinks-variant-name-sep">/</span><span class="cit-reflinks-full-text"><span class="free-full-text">FREE </span>Full Text</span></a></div>
                        </div>
                        
                     </li>
                     <li><span class="ref-label">12.</span><a class="rev-xref-ref" href="#xref-ref-12-1" title="View reference 12. in text"
                           id="ref-12">↵</a>
                        
                        
                        <div class="cit ref-cit ref-journal" id="cit-106.1.djt319.12"
                             data-doi="10.1016/0960-0760(95)00228-6">
                           <div class="cit-metadata">
                              <ol class="cit-auth-list">
                                 <li><span class="cit-auth"><span class="cit-name-surname">Hackenberg</span>  <span class="cit-name-given-names">R</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Schulz</span>  <span class="cit-name-given-names">KD</span></span></li>
                              </ol><cite>. <span class="cit-article-title">Androgen receptor mediated growth control of breast cancer and endometrial cancer modulated by antiandrogen- and androgen-like
                                    steroids</span>. <abbr class="cit-jnl-abbrev">J Steroid Biochem Mol Biol</abbr>. <span class="cit-pub-date">1996</span>;<span class="cit-vol">56</span>(<span class="cit-issue">1–6</span>):<span class="cit-fpage">113</span>–<span class="cit-lpage">117</span>.</cite></div>
                           <div class="cit-extra"><a href="/external-ref?access_num=10.1016/0960-0760(95)00228-6&amp;link_type=DOI"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-webofscience">CrossRef</a><a href="/external-ref?access_num=8603031&amp;link_type=MED"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-medline">Medline</a><a href="/external-ref?access_num=A1996UC70100015&amp;link_type=ISI"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-webofscience">Web of Science</a><a target="_blank"
                                 href="http://scholar.google.com/scholar_lookup?title=Androgen%20receptor%20mediated%20growth%20control%20of%20breast%20cancer%20and%20endometrial%20cancer%20modulated%20by%20antiandrogen-%20and%20androgen-like%20steroids&amp;author=R%20Hackenberg&amp;author=KD%20Schulz&amp;publication_year=1996&amp;journal=J%20Steroid%20Biochem%20Mol%20Biol&amp;volume=56&amp;issue=1%E2%80%936&amp;pages=113-117">Google Scholar</a></div>
                        </div>
                        
                     </li>
                     <li><span class="ref-label">13.</span><a class="rev-xref-ref" href="#xref-ref-13-1" title="View reference 13. in text"
                           id="ref-13">↵</a>
                        
                        
                        <div class="cit ref-cit ref-journal" id="cit-106.1.djt319.13"
                             data-doi="10.1158/0008-5472.SABCS-6131">
                           <div class="cit-metadata">
                              <ol class="cit-auth-list">
                                 <li><span class="cit-auth"><span class="cit-name-surname">Peters</span>  <span class="cit-name-given-names">AA</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Buchanan</span>  <span class="cit-name-given-names">G</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Ricciardelli</span>  <span class="cit-name-given-names">C</span></span>, 
                                 </li>
                                 <li><span class="cit-etal">et al.</span></li>
                              </ol><cite>
                                 <span class="cit-article-title">Androgen receptor inhibits estrogen receptor-alpha activity and is prognostic in breast cancer</span>. <abbr class="cit-jnl-abbrev">Cancer Res</abbr>. <span class="cit-pub-date">2009</span>;<span class="cit-vol">69</span>(<span class="cit-issue">15</span>):<span class="cit-fpage">6131</span>–<span class="cit-lpage">6140</span>.</cite></div>
                           <div class="cit-extra"><a href="/external-ref?access_num=10.1158/0008-5472.SABCS-6131&amp;link_type=DOI"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-webofscience">CrossRef</a><a href="/external-ref?access_num=19638585&amp;link_type=MED"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-medline">Medline</a><a href="/external-ref?access_num=000268737900017&amp;link_type=ISI"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-webofscience">Web of Science</a><a target="_blank"
                                 href="http://scholar.google.com/scholar_lookup?title=Androgen%20receptor%20inhibits%20estrogen%20receptor-alpha%20activity%20and%20is%20prognostic%20in%20breast%20cancer&amp;author=AA%20Peters&amp;author=G%20Buchanan&amp;author=C%20Ricciardelli&amp;publication_year=2009&amp;journal=Cancer%20Res&amp;volume=69&amp;issue=15&amp;pages=6131-6140">Google Scholar</a></div>
                        </div>
                        
                     </li>
                     <li><span class="ref-label">14.</span><a class="rev-xref-ref" href="#xref-ref-14-1" title="View reference 14. in text"
                           id="ref-14">↵</a>
                        
                        
                        <div class="cit ref-cit ref-journal" id="cit-106.1.djt319.14"
                             data-doi="10.1016/j.jsbmb.2007.10.014">
                           <div class="cit-metadata">
                              <ol class="cit-auth-list">
                                 <li><span class="cit-auth"><span class="cit-name-surname">Cops</span>  <span class="cit-name-given-names">EJ</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Bianco-Miotto</span>  <span class="cit-name-given-names">T</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Moore</span>  <span class="cit-name-given-names">NL</span></span>, 
                                 </li>
                                 <li><span class="cit-etal">et al.</span></li>
                              </ol><cite>
                                 <span class="cit-article-title">Antiproliferative actions of the synthetic androgen, mibolerone, in breast cancer cells are mediated by both androgen and
                                    progesterone receptors</span>. <abbr class="cit-jnl-abbrev">J Steroid Biochem Mol Biol</abbr>. <span class="cit-pub-date">2008</span>;<span class="cit-vol">110</span>(<span class="cit-issue">3–5</span>):<span class="cit-fpage">236</span>–<span class="cit-lpage">243</span>.</cite></div>
                           <div class="cit-extra"><a href="/external-ref?access_num=10.1016/j.jsbmb.2007.10.014&amp;link_type=DOI"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-webofscience">CrossRef</a><a href="/external-ref?access_num=18515094&amp;link_type=MED"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-medline">Medline</a><a target="_blank"
                                 href="http://scholar.google.com/scholar_lookup?title=Antiproliferative%20actions%20of%20the%20synthetic%20androgen%2C%20mibolerone%2C%20in%20breast%20cancer%20cells%20are%20mediated%20by%20both%20androgen%20and%20progesterone%20receptors&amp;author=EJ%20Cops&amp;author=T%20Bianco-Miotto&amp;author=NL%20Moore&amp;publication_year=2008&amp;journal=J%20Steroid%20Biochem%20Mol%20Biol&amp;volume=110&amp;issue=3%E2%80%935&amp;pages=236-243">Google Scholar</a></div>
                        </div>
                        
                     </li>
                     <li><span class="ref-label">15.</span><a class="rev-xref-ref" href="#xref-ref-15-1" title="View reference 15. in text"
                           id="ref-15">↵</a>
                        
                        
                        <div class="cit ref-cit ref-journal" id="cit-106.1.djt319.15"
                             data-doi="10.1016/S0303-7207(00)00279-3">
                           <div class="cit-metadata">
                              <ol class="cit-auth-list">
                                 <li><span class="cit-auth"><span class="cit-name-surname">Panet-Raymond</span>  <span class="cit-name-given-names">V</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Gottlieb</span>  <span class="cit-name-given-names">B</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Beitel</span>  <span class="cit-name-given-names">LK</span></span>, 
                                 </li>
                                 <li><span class="cit-etal">et al.</span></li>
                              </ol><cite>
                                 <span class="cit-article-title">Interactions between androgen and estrogen receptors and the effects on their transactivational properties</span>. <abbr class="cit-jnl-abbrev">Mol Cell Endocrinol</abbr>. <span class="cit-pub-date">2000</span>;<span class="cit-vol">167</span>(<span class="cit-issue">1–2</span>):<span class="cit-fpage">139</span>–<span class="cit-lpage">150</span>.</cite></div>
                           <div class="cit-extra"><a href="/external-ref?access_num=10.1016/S0303-7207(00)00279-3&amp;link_type=DOI"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-webofscience">CrossRef</a><a href="/external-ref?access_num=11000528&amp;link_type=MED"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-medline">Medline</a><a href="/external-ref?access_num=000089571600014&amp;link_type=ISI"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-webofscience">Web of Science</a><a target="_blank"
                                 href="http://scholar.google.com/scholar_lookup?title=Interactions%20between%20androgen%20and%20estrogen%20receptors%20and%20the%20effects%20on%20their%20transactivational%20properties&amp;author=V%20Panet-Raymond&amp;author=B%20Gottlieb&amp;author=LK%20Beitel&amp;publication_year=2000&amp;journal=Mol%20Cell%20Endocrinol&amp;volume=167&amp;issue=1%E2%80%932&amp;pages=139-150">Google Scholar</a></div>
                        </div>
                        
                     </li>
                     <li><span class="ref-label">16.</span><a class="rev-xref-ref" href="#xref-ref-16-1" title="View reference 16. in text"
                           id="ref-16">↵</a>
                        
                        
                        <div class="cit ref-cit ref-journal" id="cit-106.1.djt319.16"
                             data-doi="10.1038/emboj.2011.216">
                           <div class="cit-metadata">
                              <ol class="cit-auth-list">
                                 <li><span class="cit-auth"><span class="cit-name-surname">Robinson</span>  <span class="cit-name-given-names">JL</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Macarthur</span>  <span class="cit-name-given-names">S</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Ross-Innes</span>  <span class="cit-name-given-names">CS</span></span>, 
                                 </li>
                                 <li><span class="cit-etal">et al.</span></li>
                              </ol><cite>
                                 <span class="cit-article-title">Androgen receptor driven transcription in molecular apocrine breast cancer is mediated by FoxA1</span>. <abbr class="cit-jnl-abbrev">EMBO J</abbr>. <span class="cit-pub-date">2011</span>;<span class="cit-vol">30</span>(<span class="cit-issue">15</span>):<span class="cit-fpage">3019</span>–<span class="cit-lpage">3027</span>.</cite></div>
                           <div class="cit-extra"><a href="/cgi/ijlink?linkType=ABST&amp;journalCode=embojnl&amp;resid=30/15/3019"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-ijlinks"><span class="cit-reflinks-abstract">Abstract</span><span class="cit-sep cit-reflinks-variant-name-sep">/</span><span class="cit-reflinks-full-text"><span class="free-full-text">FREE </span>Full Text</span></a></div>
                        </div>
                        
                     </li>
                     <li><span class="ref-label">17.</span><a class="rev-xref-ref" href="#xref-ref-17-1" title="View reference 17. in text"
                           id="ref-17">↵</a>
                        
                        
                        <div class="cit ref-cit ref-journal" id="cit-106.1.djt319.17">
                           <div class="cit-metadata">
                              <ol class="cit-auth-list">
                                 <li><span class="cit-auth"><span class="cit-name-surname">Wong</span>  <span class="cit-name-given-names">YC</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Xie</span>  <span class="cit-name-given-names">B</span></span></li>
                              </ol><cite>. <span class="cit-article-title">The role of androgens in mammary carcinogenesis</span>. <abbr class="cit-jnl-abbrev">Ital J Anat Embryol</abbr>. <span class="cit-pub-date">2001</span>;<span class="cit-vol">106</span>(<span class="cit-issue">2</span>
                                 <span class="cit-supplement">Suppl 1</span>):<span class="cit-fpage">111</span>–<span class="cit-lpage">125</span>.</cite></div>
                           <div class="cit-extra"><a href="/external-ref?access_num=11729946&amp;link_type=MED"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-medline">Medline</a><a target="_blank"
                                 href="http://scholar.google.com/scholar_lookup?title=The%20role%20of%20androgens%20in%20mammary%20carcinogenesis&amp;author=YC%20Wong&amp;author=B%20Xie&amp;publication_year=2001&amp;journal=Ital%20J%20Anat%20Embryol&amp;volume=106&amp;issue=2&amp;pages=111-125">Google Scholar</a></div>
                        </div>
                        
                     </li>
                     <li><span class="ref-label">18.</span><a class="rev-xref-ref" href="#xref-ref-18-1" title="View reference 18. in text"
                           id="ref-18">↵</a>
                        
                        
                        <div class="cit ref-cit ref-journal" id="cit-106.1.djt319.18"
                             data-doi="10.1038/sj.onc.1208561">
                           <div class="cit-metadata">
                              <ol class="cit-auth-list">
                                 <li><span class="cit-auth"><span class="cit-name-surname">Farmer</span>  <span class="cit-name-given-names">P</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Bonnefoi</span>  <span class="cit-name-given-names">H</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Becette</span>  <span class="cit-name-given-names">V</span></span>, 
                                 </li>
                                 <li><span class="cit-etal">et al.</span></li>
                              </ol><cite>
                                 <span class="cit-article-title">Identification of molecular apocrine breast tumours by microarray analysis</span>. <abbr class="cit-jnl-abbrev">Oncogene</abbr>. <span class="cit-pub-date">2005</span>;<span class="cit-vol">24</span>(<span class="cit-issue">29</span>):<span class="cit-fpage">4660</span>–<span class="cit-lpage">4671</span>.</cite></div>
                           <div class="cit-extra"><a href="/external-ref?access_num=10.1038/sj.onc.1208561&amp;link_type=DOI"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-webofscience">CrossRef</a><a href="/external-ref?access_num=15897907&amp;link_type=MED"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-medline">Medline</a><a href="/external-ref?access_num=000230304500005&amp;link_type=ISI"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-webofscience">Web of Science</a><a target="_blank"
                                 href="http://scholar.google.com/scholar_lookup?title=Identification%20of%20molecular%20apocrine%20breast%20tumours%20by%20microarray%20analysis&amp;author=P%20Farmer&amp;author=H%20Bonnefoi&amp;author=V%20Becette&amp;publication_year=2005&amp;journal=Oncogene&amp;volume=24&amp;issue=29&amp;pages=4660-4671">Google Scholar</a></div>
                        </div>
                        
                     </li>
                     <li><span class="ref-label">19.</span><a class="rev-xref-ref" href="#xref-ref-19-1" title="View reference 19. in text"
                           id="ref-19">↵</a>
                        
                        
                        <div class="cit ref-cit ref-journal" id="cit-106.1.djt319.19"
                             data-doi="10.1093/jnci/djr071">
                           <div class="cit-metadata">
                              <ol class="cit-auth-list">
                                 <li><span class="cit-auth"><span class="cit-name-surname">Mackay</span>  <span class="cit-name-given-names">A</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Weigelt</span>  <span class="cit-name-given-names">B</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Grigoriadis</span>  <span class="cit-name-given-names">A</span></span>, 
                                 </li>
                                 <li><span class="cit-etal">et al.</span></li>
                              </ol><cite>
                                 <span class="cit-article-title">Microarray-based class discovery for molecular classification of breast cancer: analysis of interobserver agreement</span>. <abbr class="cit-jnl-abbrev">J Natl Cancer Inst</abbr>. <span class="cit-pub-date">2011</span>;<span class="cit-vol">103</span>(<span class="cit-issue">8</span>):<span class="cit-fpage">662</span>–<span class="cit-lpage">673</span>.</cite></div>
                           <div class="cit-extra"><a href="/cgi/ijlink?linkType=ABST&amp;journalCode=jnci&amp;resid=103/8/662"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-ijlinks"><span class="cit-reflinks-abstract">Abstract</span><span class="cit-sep cit-reflinks-variant-name-sep">/</span><span class="cit-reflinks-full-text"><span class="free-full-text">FREE </span>Full Text</span></a></div>
                        </div>
                        
                     </li>
                     <li><span class="ref-label">20.</span><a class="rev-xref-ref" href="#xref-ref-20-1" title="View reference 20. in text"
                           id="ref-20">↵</a>
                        
                        
                        <div class="cit ref-cit ref-journal" id="cit-106.1.djt319.20">
                           <div class="cit-metadata">
                              <ol class="cit-auth-list">
                                 <li><span class="cit-auth"><span class="cit-name-surname">Michiels</span>  <span class="cit-name-given-names">S</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Piedbois</span>  <span class="cit-name-given-names">P</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Burdett</span>  <span class="cit-name-given-names">S</span></span>, 
                                 </li>
                                 <li><span class="cit-etal">et al.</span></li>
                              </ol><cite>
                                 <span class="cit-article-title">Meta-analysis when only the median survival times are known: a comparison with individual patient data results</span>. <abbr class="cit-jnl-abbrev">Int J Technol Assess Health Care</abbr>. <span class="cit-pub-date">2005</span>;<span class="cit-vol">21</span>(<span class="cit-issue">1</span>):<span class="cit-fpage">119</span>–<span class="cit-lpage">125</span>.</cite></div>
                           <div class="cit-extra"><a href="/external-ref?access_num=15736523&amp;link_type=MED"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-medline">Medline</a><a href="/external-ref?access_num=000227073800015&amp;link_type=ISI"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-webofscience">Web of Science</a><a target="_blank"
                                 href="http://scholar.google.com/scholar_lookup?title=Meta-analysis%20when%20only%20the%20median%20survival%20times%20are%20known%3A%20a%20comparison%20with%20individual%20patient%20data%20results&amp;author=S%20Michiels&amp;author=P%20Piedbois&amp;author=S%20Burdett&amp;publication_year=2005&amp;journal=Int%20J%20Technol%20Assess%20Health%20Care&amp;volume=21&amp;issue=1&amp;pages=119-125">Google Scholar</a></div>
                        </div>
                        
                     </li>
                     <li><span class="ref-label">21.</span><a class="rev-xref-ref" href="#xref-ref-21-1" title="View reference 21. in text"
                           id="ref-21">↵</a>
                        
                        
                        <div class="cit ref-cit ref-book" id="cit-106.1.djt319.21">
                           <div class="cit-metadata">
                              <ol class="cit-auth-list">
                                 <li><span class="cit-auth"><span class="cit-name-surname">Deeks</span>  <span class="cit-name-given-names">JJ</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Higgins</span>  <span class="cit-name-given-names">JPT</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Altman</span>  <span class="cit-name-given-names">DG</span></span></li>
                              </ol><cite>. <span class="cit-source">Analysing and presenting results. In: Higgins JPT, Green S, ed. Cochrane Handbook for Systematic Reviews of Interventions
                                    4.2.5. Chichester, UK: John Wiley &amp; Sons; 2006</span>.</cite></div>
                           <div class="cit-extra"><a target="_blank"
                                 href="http://scholar.google.com/scholar_lookup?title=Analysing%20and%20presenting%20results.%20In%3A%20Higgins%20JPT%2C%20Green%20S%2C%20ed.%20Cochrane%20Handbook%20for%20Systematic%20Reviews%20of%20Interventions%204.2.5.%20Chichester%2C%20UK%3A%20John%20Wiley%20%26%20Sons%3B%202006&amp;author=JJ%20Deeks&amp;author=JPT%20Higgins&amp;author=DG%20Altman">Google Scholar</a></div>
                        </div>
                        
                     </li>
                     <li><span class="ref-label">22.</span><a class="rev-xref-ref" href="#xref-ref-22-2" title="View reference 22. in text"
                           id="ref-22">↵</a>
                        
                        
                        <div class="cit ref-cit ref-journal" id="cit-106.1.djt319.22"
                             data-doi="10.2478/v10042-008-0039-y">
                           <div class="cit-metadata">
                              <ol class="cit-auth-list">
                                 <li><span class="cit-auth"><span class="cit-name-surname">Agrawal</span>  <span class="cit-name-given-names">AK</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Jelen</span>  <span class="cit-name-given-names">M</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Grzebieniak</span>  <span class="cit-name-given-names">Z</span></span>, 
                                 </li>
                                 <li><span class="cit-etal">et al.</span></li>
                              </ol><cite>
                                 <span class="cit-article-title">Androgen receptors as a prognostic and predictive factor in breast cancer</span>. <abbr class="cit-jnl-abbrev">Folia Histochem Cytobiol</abbr>. <span class="cit-pub-date">2008</span>;<span class="cit-vol">46</span>(<span class="cit-issue">3</span>):<span class="cit-fpage">269</span>–<span class="cit-lpage">276</span>.</cite></div>
                           <div class="cit-extra"><a href="/external-ref?access_num=10.2478/v10042-008-0039-y&amp;link_type=DOI"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-webofscience">CrossRef</a><a href="/external-ref?access_num=19056529&amp;link_type=MED"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-medline">Medline</a><a target="_blank"
                                 href="http://scholar.google.com/scholar_lookup?title=Androgen%20receptors%20as%20a%20prognostic%20and%20predictive%20factor%20in%20breast%20cancer&amp;author=AK%20Agrawal&amp;author=M%20Jelen&amp;author=Z%20Grzebieniak&amp;publication_year=2008&amp;journal=Folia%20Histochem%20Cytobiol&amp;volume=46&amp;issue=3&amp;pages=269-276">Google Scholar</a></div>
                        </div>
                        
                     </li>
                     <li><span class="ref-label">23.</span><a class="rev-xref-ref" href="#xref-ref-23-2" title="View reference 23. in text"
                           id="ref-23">↵</a>
                        
                        
                        <div class="cit ref-cit ref-journal" id="cit-106.1.djt319.23">
                           <div class="cit-metadata">
                              <ol class="cit-auth-list">
                                 <li><span class="cit-auth"><span class="cit-name-surname">Honma</span>  <span class="cit-name-given-names">N</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Horii</span>  <span class="cit-name-given-names">R</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Iwase</span>  <span class="cit-name-given-names">T</span></span>, 
                                 </li>
                                 <li><span class="cit-etal">et al.</span></li>
                              </ol><cite>
                                 <span class="cit-article-title">Clinical importance of androgen receptor in breast cancer patients treated with adjuvant tamoxifen monotherapy</span>. <abbr class="cit-jnl-abbrev">Breast Cancer</abbr>. <span class="cit-pub-date">2012 Feb 4. [Epub ahead of print]</span>.</cite></div>
                           <div class="cit-extra"><a target="_blank"
                                 href="http://scholar.google.com/scholar_lookup?title=Clinical%20importance%20of%20androgen%20receptor%20in%20breast%20cancer%20patients%20treated%20with%20adjuvant%20tamoxifen%20monotherapy&amp;author=N%20Honma&amp;author=R%20Horii&amp;author=T%20Iwase&amp;publication_year=2012%20Feb%204.%20%5BEpub%20ahead%20of%20print%5D&amp;journal=Breast%20Cancer">Google Scholar</a></div>
                        </div>
                        
                     </li>
                     <li><span class="ref-label">24.</span><a class="rev-xref-ref" href="#xref-ref-24-2" title="View reference 24. in text"
                           id="ref-24">↵</a>
                        
                        
                        <div class="cit ref-cit ref-journal" id="cit-106.1.djt319.24"
                             data-doi="10.1093/annonc/mdp510">
                           <div class="cit-metadata">
                              <ol class="cit-auth-list">
                                 <li><span class="cit-auth"><span class="cit-name-surname">Park</span>  <span class="cit-name-given-names">S</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Koo</span>  <span class="cit-name-given-names">J</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Park</span>  <span class="cit-name-given-names">HS</span></span>, 
                                 </li>
                                 <li><span class="cit-etal">et al.</span></li>
                              </ol><cite>
                                 <span class="cit-article-title">Expression of androgen receptors in primary breast cancer</span>. <abbr class="cit-jnl-abbrev">Ann Oncol</abbr>. <span class="cit-pub-date">2010</span>;<span class="cit-vol">21</span>(<span class="cit-issue">3</span>):<span class="cit-fpage">488</span>–<span class="cit-lpage">492</span>.</cite></div>
                           <div class="cit-extra"><a href="/cgi/ijlink?linkType=ABST&amp;journalCode=annonc&amp;resid=21/3/488"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-ijlinks"><span class="cit-reflinks-abstract">Abstract</span><span class="cit-sep cit-reflinks-variant-name-sep">/</span><span class="cit-reflinks-full-text"><span class="free-full-text">FREE </span>Full Text</span></a></div>
                        </div>
                        
                     </li>
                     <li><span class="ref-label">25.</span><a class="rev-xref-ref" href="#xref-ref-25-1" title="View reference 25. in text"
                           id="ref-25">↵</a>
                        
                        
                        <div class="cit ref-cit ref-journal" id="cit-106.1.djt319.25"
                             data-doi="10.1200/JCO.2002.02.026">
                           <div class="cit-metadata">
                              <ol class="cit-auth-list">
                                 <li><span class="cit-auth"><span class="cit-name-surname">Singletary</span>  <span class="cit-name-given-names">SE</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Allred</span>  <span class="cit-name-given-names">C</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Ashley</span>  <span class="cit-name-given-names">P</span></span>, 
                                 </li>
                                 <li><span class="cit-etal">et al.</span></li>
                              </ol><cite>
                                 <span class="cit-article-title">Revision of the American Joint Committee on Cancer staging system for breast cancer</span>. <abbr class="cit-jnl-abbrev">J Clin Oncol</abbr>. <span class="cit-pub-date">2002</span>;<span class="cit-vol">20</span>(<span class="cit-issue">17</span>):<span class="cit-fpage">3628</span>–<span class="cit-lpage">3636</span>.</cite></div>
                           <div class="cit-extra"><a href="/cgi/ijlink?linkType=ABST&amp;journalCode=jco&amp;resid=20/17/3628"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-ijlinks"><span class="cit-reflinks-abstract">Abstract</span><span class="cit-sep cit-reflinks-variant-name-sep">/</span><span class="cit-reflinks-full-text"><span class="free-full-text">FREE </span>Full Text</span></a></div>
                        </div>
                        
                     </li>
                     <li><span class="ref-label">26.</span><a class="rev-xref-ref" href="#xref-ref-26-1" title="View reference 26. in text"
                           id="ref-26">↵</a>
                        
                        
                        <div class="cit ref-cit ref-journal" id="cit-106.1.djt319.26"
                             data-doi="10.1007/s00432-013-1382-8">
                           <div class="cit-metadata">
                              <ol class="cit-auth-list">
                                 <li><span class="cit-auth"><span class="cit-name-surname">Witzel</span>  <span class="cit-name-given-names">I</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Graeser</span>  <span class="cit-name-given-names">M</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Karn</span>  <span class="cit-name-given-names">T</span></span>, 
                                 </li>
                                 <li><span class="cit-etal">et al.</span></li>
                              </ol><cite>
                                 <span class="cit-article-title">Androgen receptor expression is a predictive marker in chemotherapy-treated patients with endocrine receptor-positive primary
                                    breast cancers</span>. <abbr class="cit-jnl-abbrev">J Cancer Res Clin Oncol</abbr>. <span class="cit-pub-date">2013</span>;<span class="cit-vol">139</span>(<span class="cit-issue">5</span>):<span class="cit-fpage">809</span>–<span class="cit-lpage">816</span>.</cite></div>
                           <div class="cit-extra"><a href="/external-ref?access_num=10.1007/s00432-013-1382-8&amp;link_type=DOI"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-webofscience">CrossRef</a><a href="/external-ref?access_num=23392859&amp;link_type=MED"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-medline">Medline</a><a target="_blank"
                                 href="http://scholar.google.com/scholar_lookup?title=Androgen%20receptor%20expression%20is%20a%20predictive%20marker%20in%20chemotherapy-treated%20patients%20with%20endocrine%20receptor-positive%20primary%20breast%20cancers&amp;author=I%20Witzel&amp;author=M%20Graeser&amp;author=T%20Karn&amp;publication_year=2013&amp;journal=J%20Cancer%20Res%20Clin%20Oncol&amp;volume=139&amp;issue=5&amp;pages=809-816">Google Scholar</a></div>
                        </div>
                        
                     </li>
                     <li><span class="ref-label">27.</span><a class="rev-xref-ref" href="#xref-ref-27-1" title="View reference 27. in text"
                           id="ref-27">↵</a>
                        
                        
                        <div class="cit ref-cit ref-journal" id="cit-106.1.djt319.27"
                             data-doi="10.1038/modpathol.2009.159">
                           <div class="cit-metadata">
                              <ol class="cit-auth-list">
                                 <li><span class="cit-auth"><span class="cit-name-surname">Niemeier</span>  <span class="cit-name-given-names">LA</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Dabbs</span>  <span class="cit-name-given-names">DJ</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Beriwal</span>  <span class="cit-name-given-names">S</span></span>, 
                                 </li>
                                 <li><span class="cit-etal">et al.</span></li>
                              </ol><cite>
                                 <span class="cit-article-title">Androgen receptor in breast cancer: expression in estrogen receptor-positive tumors and in estrogen receptor-negative tumors
                                    with apocrine differentiation</span>. <abbr class="cit-jnl-abbrev">Mod Pathol</abbr>. <span class="cit-pub-date">2010</span>;<span class="cit-vol">23</span>(<span class="cit-issue">2</span>):<span class="cit-fpage">205</span>–<span class="cit-lpage">212</span>.</cite></div>
                           <div class="cit-extra"><a href="/external-ref?access_num=10.1038/modpathol.2009.159&amp;link_type=DOI"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-webofscience">CrossRef</a><a href="/external-ref?access_num=19898421&amp;link_type=MED"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-medline">Medline</a><a href="/external-ref?access_num=000274233100006&amp;link_type=ISI"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-webofscience">Web of Science</a><a target="_blank"
                                 href="http://scholar.google.com/scholar_lookup?title=Androgen%20receptor%20in%20breast%20cancer%3A%20expression%20in%20estrogen%20receptor-positive%20tumors%20and%20in%20estrogen%20receptor-negative%20tumors%20with%20apocrine%20differentiation&amp;author=LA%20Niemeier&amp;author=DJ%20Dabbs&amp;author=S%20Beriwal&amp;publication_year=2010&amp;journal=Mod%20Pathol&amp;volume=23&amp;issue=2&amp;pages=205-212">Google Scholar</a></div>
                        </div>
                        
                     </li>
                     <li><span class="ref-label">28.</span><a class="rev-xref-ref" href="#xref-ref-28-1" title="View reference 28. in text"
                           id="ref-28">↵</a>
                        
                        
                        <div class="cit ref-cit ref-journal" id="cit-106.1.djt319.28">
                           <div class="cit-metadata">
                              <ol class="cit-auth-list">
                                 <li><span class="cit-auth"><span class="cit-name-surname">Naderi</span>  <span class="cit-name-given-names">A</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Hughes-Davies</span>  <span class="cit-name-given-names">L</span></span></li>
                              </ol><cite>. <span class="cit-article-title">A functionally significant cross-talk between androgen receptor and ErbB2 pathways in estrogen receptor negative breast cancer</span>. <abbr class="cit-jnl-abbrev">Neoplasia</abbr>. <span class="cit-pub-date">2008</span>;<span class="cit-vol">10</span>(<span class="cit-issue">6</span>):<span class="cit-fpage">542</span>–<span class="cit-lpage">548</span>.</cite></div>
                           <div class="cit-extra"><a href="/external-ref?access_num=18516291&amp;link_type=MED"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-medline">Medline</a><a href="/external-ref?access_num=000255885200003&amp;link_type=ISI"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-webofscience">Web of Science</a><a target="_blank"
                                 href="http://scholar.google.com/scholar_lookup?title=A%20functionally%20significant%20cross-talk%20between%20androgen%20receptor%20and%20ErbB2%20pathways%20in%20estrogen%20receptor%20negative%20breast%20cancer&amp;author=A%20Naderi&amp;author=L%20Hughes-Davies&amp;publication_year=2008&amp;journal=Neoplasia&amp;volume=10&amp;issue=6&amp;pages=542-548">Google Scholar</a></div>
                        </div>
                        
                     </li>
                     <li><span class="ref-label">29.</span><a class="rev-xref-ref" href="#xref-ref-29-1" title="View reference 29. in text"
                           id="ref-29">↵</a>
                        
                        
                        <div class="cit ref-cit ref-journal" id="cit-106.1.djt319.29">
                           <div class="cit-metadata">
                              <ol class="cit-auth-list">
                                 <li><span class="cit-auth"><span class="cit-name-surname">Agrawal</span>  <span class="cit-name-given-names">A</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Robertson</span>  <span class="cit-name-given-names">JF</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Cheung</span>  <span class="cit-name-given-names">KL</span></span></li>
                              </ol><cite>. <span class="cit-article-title">“Resurrection of clinical efficacy” after resistance to endocrine therapy in metastatic breast cancer</span>. <abbr class="cit-jnl-abbrev">World J Surg Oncol</abbr>. <span class="cit-pub-date">2006 Jul 5;4:40.</span>
                                 </cite></div>
                           <div class="cit-extra"><a target="_blank"
                                 href="http://scholar.google.com/scholar_lookup?title=%E2%80%9CResurrection%20of%20clinical%20efficacy%E2%80%9D%20after%20resistance%20to%20endocrine%20therapy%20in%20metastatic%20breast%20cancer&amp;author=A%20Agrawal&amp;author=JF%20Robertson&amp;author=KL%20Cheung&amp;publication_year=2006%20Jul%205%3B4%3A40.&amp;journal=World%20J%20Surg%20Oncol">Google Scholar</a></div>
                        </div>
                        
                     </li>
                     <li><span class="ref-label">30.</span><a class="rev-xref-ref" href="#xref-ref-30-1" title="View reference 30. in text"
                           id="ref-30">↵</a>
                        
                        
                        <div class="cit ref-cit ref-journal" id="cit-106.1.djt319.30"
                             data-doi="10.1093/jnci/80.10.756">
                           <div class="cit-metadata">
                              <ol class="cit-auth-list">
                                 <li><span class="cit-auth"><span class="cit-name-surname">Raam</span>  <span class="cit-name-given-names">S</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Robert</span>  <span class="cit-name-given-names">N</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Pappas</span>  <span class="cit-name-given-names">CA</span></span>, 
                                 </li>
                                 <li><span class="cit-etal">et al.</span></li>
                              </ol><cite>
                                 <span class="cit-article-title">Defective estrogen receptors in human mammary cancers: their significance in defining hormone dependence</span>. <abbr class="cit-jnl-abbrev">J Natl Cancer Inst</abbr>. <span class="cit-pub-date">1988</span>;<span class="cit-vol">80</span>(<span class="cit-issue">10</span>):<span class="cit-fpage">756</span>–<span class="cit-lpage">761</span>.</cite></div>
                           <div class="cit-extra"><a href="/cgi/ijlink?linkType=ABST&amp;journalCode=jnci&amp;resid=80/10/756"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-ijlinks"><span class="cit-reflinks-abstract">Abstract</span><span class="cit-sep cit-reflinks-variant-name-sep">/</span><span class="cit-reflinks-full-text"><span class="free-full-text">FREE </span>Full Text</span></a></div>
                        </div>
                        
                     </li>
                     <li><span class="ref-label">31.</span>
                        
                        
                        <div class="cit ref-cit ref-journal no-rev-xref" id="cit-106.1.djt319.31"
                             data-doi="10.1016/0960-0760(92)90214-4">
                           <div class="cit-metadata">
                              <ol class="cit-auth-list">
                                 <li><span class="cit-auth"><span class="cit-name-surname">McGuire</span>  <span class="cit-name-given-names">WL</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Chamness</span>  <span class="cit-name-given-names">GC</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Fuqua</span>  <span class="cit-name-given-names">SA</span></span></li>
                              </ol><cite>. <span class="cit-article-title">Abnormal estrogen receptor in clinical breast cancer</span>. <abbr class="cit-jnl-abbrev">J Steroid Biochem Mol Biol</abbr>. <span class="cit-pub-date">1992</span>;<span class="cit-vol">43</span>(<span class="cit-issue">1–3</span>):<span class="cit-fpage">243</span>–<span class="cit-lpage">247</span>.</cite></div>
                           <div class="cit-extra"><a href="/external-ref?access_num=10.1016/0960-0760(92)90214-4&amp;link_type=DOI"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-webofscience">CrossRef</a><a href="/external-ref?access_num=1525064&amp;link_type=MED"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-medline">Medline</a><a href="/external-ref?access_num=A1992JM32400036&amp;link_type=ISI"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-webofscience">Web of Science</a><a target="_blank"
                                 href="http://scholar.google.com/scholar_lookup?title=Abnormal%20estrogen%20receptor%20in%20clinical%20breast%20cancer&amp;author=WL%20McGuire&amp;author=GC%20Chamness&amp;author=SA%20Fuqua&amp;publication_year=1992&amp;journal=J%20Steroid%20Biochem%20Mol%20Biol&amp;volume=43&amp;issue=1%E2%80%933&amp;pages=243-247">Google Scholar</a></div>
                        </div>
                        
                     </li>
                     <li><span class="ref-label">32.</span>
                        
                        
                        <div class="cit ref-cit ref-journal no-rev-xref" id="cit-106.1.djt319.32">
                           <div class="cit-metadata">
                              <ol class="cit-auth-list">
                                 <li><span class="cit-auth"><span class="cit-name-surname">Faridi</span>  <span class="cit-name-given-names">J</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Wang</span>  <span class="cit-name-given-names">L</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Endemann</span>  <span class="cit-name-given-names">G</span></span>, 
                                 </li>
                                 <li><span class="cit-etal">et al.</span></li>
                              </ol><cite>
                                 <span class="cit-article-title">Expression of constitutively active Akt-3 in MCF-7 breast cancer cells reverses the estrogen and tamoxifen responsivity of
                                    these cells in vivo</span>. <abbr class="cit-jnl-abbrev">Clin Cancer Res</abbr>. <span class="cit-pub-date">2003</span>;<span class="cit-vol">9</span>(<span class="cit-issue">8</span>):<span class="cit-fpage">2933</span>–<span class="cit-lpage">2939</span>.</cite></div>
                           <div class="cit-extra"><a href="/cgi/ijlink?linkType=ABST&amp;journalCode=clincanres&amp;resid=9/8/2933"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-ijlinks"><span class="cit-reflinks-abstract">Abstract</span><span class="cit-sep cit-reflinks-variant-name-sep">/</span><span class="cit-reflinks-full-text"><span class="free-full-text">FREE </span>Full Text</span></a></div>
                        </div>
                        
                     </li>
                     <li><span class="ref-label">33.</span>
                        
                        
                        <div class="cit ref-cit ref-journal no-rev-xref" id="cit-106.1.djt319.33">
                           <div class="cit-metadata">
                              <ol class="cit-auth-list">
                                 <li><span class="cit-auth"><span class="cit-name-surname">Hui</span>  <span class="cit-name-given-names">R</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Finney</span>  <span class="cit-name-given-names">GL</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Carroll</span>  <span class="cit-name-given-names">JS</span></span>, 
                                 </li>
                                 <li><span class="cit-etal">et al.</span></li>
                              </ol><cite>
                                 <span class="cit-article-title">Constitutive overexpression of cyclin D1 but not cyclin E confers acute resistance to antiestrogens in T-47D breast cancer
                                    cells</span>. <abbr class="cit-jnl-abbrev">Cancer Res</abbr>. <span class="cit-pub-date">2002</span>;<span class="cit-vol">62</span>(<span class="cit-issue">23</span>):<span class="cit-fpage">6916</span>–<span class="cit-lpage">6923</span>.</cite></div>
                           <div class="cit-extra"><a href="/cgi/ijlink?linkType=ABST&amp;journalCode=canres&amp;resid=62/23/6916"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-ijlinks"><span class="cit-reflinks-abstract">Abstract</span><span class="cit-sep cit-reflinks-variant-name-sep">/</span><span class="cit-reflinks-full-text"><span class="free-full-text">FREE </span>Full Text</span></a></div>
                        </div>
                        
                     </li>
                     <li><span class="ref-label">34.</span>
                        
                        
                        <div class="cit ref-cit ref-journal no-rev-xref" id="cit-106.1.djt319.34"
                             data-doi="10.1158/0008-5472.CAN-09-0042">
                           <div class="cit-metadata">
                              <ol class="cit-auth-list">
                                 <li><span class="cit-auth"><span class="cit-name-surname">Miller</span>  <span class="cit-name-given-names">TW</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Perez-Torres</span>  <span class="cit-name-given-names">M</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Narasanna</span>  <span class="cit-name-given-names">A</span></span>, 
                                 </li>
                                 <li><span class="cit-etal">et al.</span></li>
                              </ol><cite>
                                 <span class="cit-article-title">Loss of phosphatase and tensin homologue deleted on chromosome 10 engages ErbB3 and insulin-like growth factor-I receptor
                                    signaling to promote antiestrogen resistance in breast cancer</span>. <abbr class="cit-jnl-abbrev">Cancer Res</abbr>. <span class="cit-pub-date">2009</span>;<span class="cit-vol">69</span>(<span class="cit-issue">10</span>):<span class="cit-fpage">4192</span>–<span class="cit-lpage">4201</span>.</cite></div>
                           <div class="cit-extra"><a href="/cgi/ijlink?linkType=ABST&amp;journalCode=canres&amp;resid=69/10/4192"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-ijlinks"><span class="cit-reflinks-abstract">Abstract</span><span class="cit-sep cit-reflinks-variant-name-sep">/</span><span class="cit-reflinks-full-text"><span class="free-full-text">FREE </span>Full Text</span></a></div>
                        </div>
                        
                     </li>
                     <li><span class="ref-label">35.</span>
                        
                        
                        <div class="cit ref-cit ref-journal no-rev-xref" id="cit-106.1.djt319.35">
                           <div class="cit-metadata">
                              <ol class="cit-auth-list">
                                 <li><span class="cit-auth"><span class="cit-name-surname">Prall</span>  <span class="cit-name-given-names">OW</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Rogan</span>  <span class="cit-name-given-names">EM</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Musgrove</span>  <span class="cit-name-given-names">EA</span></span>, 
                                 </li>
                                 <li><span class="cit-etal">et al.</span></li>
                              </ol><cite>
                                 <span class="cit-article-title">c-Myc or cyclin D1 mimics estrogen effects on cyclin E-Cdk2 activation and cell cycle reentry</span>. <abbr class="cit-jnl-abbrev">Mol Cell Biol</abbr>. <span class="cit-pub-date">1998</span>;<span class="cit-vol">18</span>(<span class="cit-issue">8</span>):<span class="cit-fpage">4499</span>–<span class="cit-lpage">4508</span>.</cite></div>
                           <div class="cit-extra"><a href="/cgi/ijlink?linkType=ABST&amp;journalCode=mcb&amp;resid=18/8/4499"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-ijlinks"><span class="cit-reflinks-abstract">Abstract</span><span class="cit-sep cit-reflinks-variant-name-sep">/</span><span class="cit-reflinks-full-text"><span class="free-full-text">FREE </span>Full Text</span></a></div>
                        </div>
                        
                     </li>
                     <li><span class="ref-label">36.</span><a class="rev-xref-ref" href="#xref-ref-36-1" title="View reference 36. in text"
                           id="ref-36">↵</a>
                        
                        
                        <div class="cit ref-cit ref-journal" id="cit-106.1.djt319.36"
                             data-doi="10.1007/s10549-009-0436-8">
                           <div class="cit-metadata">
                              <ol class="cit-auth-list">
                                 <li><span class="cit-auth"><span class="cit-name-surname">De Amicis</span>  <span class="cit-name-given-names">F</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Thirugnansampanthan</span>  <span class="cit-name-given-names">J</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Cui</span>  <span class="cit-name-given-names">Y</span></span>, 
                                 </li>
                                 <li><span class="cit-etal">et al.</span></li>
                              </ol><cite>
                                 <span class="cit-article-title">Androgen receptor overexpression induces tamoxifen resistance in human breast cancer cells</span>. <abbr class="cit-jnl-abbrev">Breast Cancer Res Treat</abbr>. <span class="cit-pub-date">2010</span>;<span class="cit-vol">121</span>(<span class="cit-issue">1</span>):<span class="cit-fpage">1</span>–<span class="cit-lpage">11</span>.</cite></div>
                           <div class="cit-extra"><a href="/external-ref?access_num=10.1007/s10549-009-0436-8&amp;link_type=DOI"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-webofscience">CrossRef</a><a href="/external-ref?access_num=19533338&amp;link_type=MED"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-medline">Medline</a><a href="/external-ref?access_num=000276758200001&amp;link_type=ISI"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-webofscience">Web of Science</a><a target="_blank"
                                 href="http://scholar.google.com/scholar_lookup?title=Androgen%20receptor%20overexpression%20induces%20tamoxifen%20resistance%20in%20human%20breast%20cancer%20cells&amp;author=F%20De%20Amicis&amp;author=J%20Thirugnansampanthan&amp;author=Y%20Cui&amp;publication_year=2010&amp;journal=Breast%20Cancer%20Res%20Treat&amp;volume=121&amp;issue=1&amp;pages=1-11">Google Scholar</a></div>
                        </div>
                        
                     </li>
                     <li><span class="ref-label">37.</span><a class="rev-xref-ref" href="#xref-ref-37-1" title="View reference 37. in text"
                           id="ref-37">↵</a>
                        
                        
                        <div class="cit ref-cit ref-journal" id="cit-106.1.djt319.37"
                             data-doi="10.1056/NEJMoa1207506">
                           <div class="cit-metadata">
                              <ol class="cit-auth-list">
                                 <li><span class="cit-auth"><span class="cit-name-surname">Scher</span>  <span class="cit-name-given-names">HI</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Fizazi</span>  <span class="cit-name-given-names">K</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Saad</span>  <span class="cit-name-given-names">F</span></span>, 
                                 </li>
                                 <li><span class="cit-etal">et al.</span></li>
                              </ol><cite>
                                 <span class="cit-article-title">Increased survival with enzalutamide in prostate cancer after chemotherapy</span>. <abbr class="cit-jnl-abbrev">N Engl J Med</abbr>. <span class="cit-pub-date">2012</span>;<span class="cit-vol">367</span>(<span class="cit-issue">13</span>):<span class="cit-fpage">1187</span>–<span class="cit-lpage">1197</span>.</cite></div>
                           <div class="cit-extra"><a href="/external-ref?access_num=10.1056/NEJMoa1207506&amp;link_type=DOI"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-webofscience">CrossRef</a><a href="/external-ref?access_num=22894553&amp;link_type=MED"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-medline">Medline</a><a href="/external-ref?access_num=000309161100005&amp;link_type=ISI"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-webofscience">Web of Science</a><a target="_blank"
                                 href="http://scholar.google.com/scholar_lookup?title=Increased%20survival%20with%20enzalutamide%20in%20prostate%20cancer%20after%20chemotherapy&amp;author=HI%20Scher&amp;author=K%20Fizazi&amp;author=F%20Saad&amp;publication_year=2012&amp;journal=N%20Engl%20J%20Med&amp;volume=367&amp;issue=13&amp;pages=1187-1197">Google Scholar</a></div>
                        </div>
                        
                     </li>
                     <li><span class="ref-label">38.</span><a class="rev-xref-ref" href="#xref-ref-38-1" title="View reference 38. in text"
                           id="ref-38">↵</a>
                        
                        
                        <div class="cit ref-cit ref-journal" id="cit-106.1.djt319.38"
                             data-doi="10.1056/NEJMoa1014618">
                           <div class="cit-metadata">
                              <ol class="cit-auth-list">
                                 <li><span class="cit-auth"><span class="cit-name-surname">de Bono</span>  <span class="cit-name-given-names">JS</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Logothetis</span>  <span class="cit-name-given-names">CJ</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Molina</span>  <span class="cit-name-given-names">A</span></span>, 
                                 </li>
                                 <li><span class="cit-etal">et al.</span></li>
                              </ol><cite>
                                 <span class="cit-article-title">Abiraterone and increased survival in metastatic prostate cancer</span>. <abbr class="cit-jnl-abbrev">N Engl J Med</abbr>. <span class="cit-pub-date">2011</span>;<span class="cit-vol">364</span>(<span class="cit-issue">21</span>):<span class="cit-fpage">1995</span>–<span class="cit-lpage">2005</span>.</cite></div>
                           <div class="cit-extra"><a href="/external-ref?access_num=10.1056/NEJMoa1014618&amp;link_type=DOI"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-webofscience">CrossRef</a><a href="/external-ref?access_num=21612468&amp;link_type=MED"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-medline">Medline</a><a href="/external-ref?access_num=000290952000004&amp;link_type=ISI"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-webofscience">Web of Science</a><a target="_blank"
                                 href="http://scholar.google.com/scholar_lookup?title=Abiraterone%20and%20increased%20survival%20in%20metastatic%20prostate%20cancer&amp;author=JS%20de%20Bono&amp;author=CJ%20Logothetis&amp;author=A%20Molina&amp;publication_year=2011&amp;journal=N%20Engl%20J%20Med&amp;volume=364&amp;issue=21&amp;pages=1995-2005">Google Scholar</a></div>
                        </div>
                        
                     </li>
                     <li><span class="ref-label">39.</span><a class="rev-xref-ref" href="#xref-ref-39-1" title="View reference 39. in text"
                           id="ref-39">↵</a>
                        
                        
                        <div class="cit ref-cit ref-journal" id="cit-106.1.djt319.39">
                           <div class="cit-metadata"><cite><abbr class="cit-jnl-abbrev">Abiraterone Acetate in Treating Postmenopausal Women With Advanced or Metastatic Breast Cancer</abbr>. <a href="http://www.clinicaltrials.gov/ct2/show/NCT00755885?term=abiraterone+breast+cancer&amp;rank=2">http://www.clinicaltrials.gov/ct2/show/<a href="/external-ref?link_type=CLINTRIALGOV&amp;access_num=NCT00755885">NCT00755885</a>?term=abiraterone+breast+cancer&amp;rank=2</a>. <span class="cit-comment">Accessed October 11</span>, <span class="cit-pub-date">2013</span>.</cite></div>
                           <div class="cit-extra"></div>
                        </div>
                        
                     </li>
                     <li><span class="ref-label">40.</span><a class="rev-xref-ref" href="#xref-ref-40-1" title="View reference 40. in text"
                           id="ref-40">↵</a>
                        
                        
                        <div class="cit ref-cit ref-journal" id="cit-106.1.djt319.40">
                           <div class="cit-metadata"><cite><abbr class="cit-jnl-abbrev">A Study of Abiraterone Acetate Plus Prednisone With or Without Exemestane in Postmenopausal Women With Estrogen Receptor-Positive
                                    (ER+) Metastatic Breast Cancer Progressing After Letrozole or Anastrozole Therapy</abbr>. <a href="http://www.clinicaltrials.gov/ct2/show/study/NCT01381874?term=abiraterone+breast+cancer&amp;rank=1&amp;show_locs=Y#locn">http://www.clinicaltrials.gov/ct2/show/study/<a href="/external-ref?link_type=CLINTRIALGOV&amp;access_num=NCT01381874">NCT01381874</a>?term=abiraterone+breast+cancer&amp;rank=1&amp;show_locs=Y#locn</a>. <span class="cit-comment">Accessed October 11</span>, <span class="cit-pub-date">2013</span>.</cite></div>
                           <div class="cit-extra"></div>
                        </div>
                        
                     </li>
                     <li><span class="ref-label">41.</span>
                        
                        
                        <div class="cit ref-cit ref-journal no-rev-xref" id="cit-106.1.djt319.41"
                             data-doi="10.1007/s10549-006-9310-0">
                           <div class="cit-metadata">
                              <ol class="cit-auth-list">
                                 <li><span class="cit-auth"><span class="cit-name-surname">Carreno</span>  <span class="cit-name-given-names">G</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Del Casar</span>  <span class="cit-name-given-names">JM</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Corte</span>  <span class="cit-name-given-names">MD</span></span>, 
                                 </li>
                                 <li><span class="cit-etal">et al.</span></li>
                              </ol><cite>
                                 <span class="cit-article-title">Local recurrence after mastectomy for breast cancer: analysis of clinicopathological, biological and prognostic characteristics</span>. <abbr class="cit-jnl-abbrev">Breast Cancer Res Treat</abbr>. <span class="cit-pub-date">2007</span>;<span class="cit-vol">102</span>(<span class="cit-issue">1</span>):<span class="cit-fpage">61</span>–<span class="cit-lpage">73</span>.</cite></div>
                           <div class="cit-extra"><a href="/external-ref?access_num=10.1007/s10549-006-9310-0&amp;link_type=DOI"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-webofscience">CrossRef</a><a href="/external-ref?access_num=16850244&amp;link_type=MED"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-medline">Medline</a><a href="/external-ref?access_num=000244302800007&amp;link_type=ISI"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-webofscience">Web of Science</a><a target="_blank"
                                 href="http://scholar.google.com/scholar_lookup?title=Local%20recurrence%20after%20mastectomy%20for%20breast%20cancer%3A%20analysis%20of%20clinicopathological%2C%20biological%20and%20prognostic%20characteristics&amp;author=G%20Carreno&amp;author=JM%20Del%20Casar&amp;author=MD%20Corte&amp;publication_year=2007&amp;journal=Breast%20Cancer%20Res%20Treat&amp;volume=102&amp;issue=1&amp;pages=61-73">Google Scholar</a></div>
                        </div>
                        
                     </li>
                     <li><span class="ref-label">42.</span>
                        
                        
                        <div class="cit ref-cit ref-journal no-rev-xref" id="cit-106.1.djt319.42"
                             data-doi="10.1016/0959-8049(96)00112-8">
                           <div class="cit-metadata">
                              <ol class="cit-auth-list">
                                 <li><span class="cit-auth"><span class="cit-name-surname">Kuenen-Boumeester</span>  <span class="cit-name-given-names">V</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Van der Kwast</span>  <span class="cit-name-given-names">TH</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Claassen</span>  <span class="cit-name-given-names">CC</span></span>, 
                                 </li>
                                 <li><span class="cit-etal">et al.</span></li>
                              </ol><cite>
                                 <span class="cit-article-title">The clinical significance of androgen receptors in breast cancer and their relation to histological and cell biological parameters</span>. <abbr class="cit-jnl-abbrev">Eur J Cancer</abbr>. <span class="cit-pub-date">1996</span>;<span class="cit-vol">32A</span>(<span class="cit-issue">9</span>):<span class="cit-fpage">1560</span>–<span class="cit-lpage">1565</span>.</cite></div>
                           <div class="cit-extra"><a href="/external-ref?access_num=10.1016/0959-8049(96)00112-8&amp;link_type=DOI"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-webofscience">CrossRef</a><a target="_blank"
                                 href="http://scholar.google.com/scholar_lookup?title=The%20clinical%20significance%20of%20androgen%20receptors%20in%20breast%20cancer%20and%20their%20relation%20to%20histological%20and%20cell%20biological%20parameters&amp;author=V%20Kuenen-Boumeester&amp;author=TH%20Van%20der%20Kwast&amp;author=CC%20Claassen&amp;publication_year=1996&amp;journal=Eur%20J%20Cancer&amp;volume=32A&amp;issue=9&amp;pages=1560-1565">Google Scholar</a></div>
                        </div>
                        
                     </li>
                     <li><span class="ref-label">43.</span>
                        
                        
                        <div class="cit ref-cit ref-journal no-rev-xref" id="cit-106.1.djt319.43"
                             data-doi="10.1093/annonc/mdq586">
                           <div class="cit-metadata">
                              <ol class="cit-auth-list">
                                 <li><span class="cit-auth"><span class="cit-name-surname">Yu</span>  <span class="cit-name-given-names">Q</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Niu</span>  <span class="cit-name-given-names">Y</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Liu</span>  <span class="cit-name-given-names">N</span></span>, 
                                 </li>
                                 <li><span class="cit-etal">et al.</span></li>
                              </ol><cite>
                                 <span class="cit-article-title">Expression of androgen receptor in breast cancer and its significance as a prognostic factor</span>. <abbr class="cit-jnl-abbrev">Ann Oncol</abbr>. <span class="cit-pub-date">2011</span>;<span class="cit-vol">22</span>(<span class="cit-issue">6</span>):<span class="cit-fpage">1288</span>–<span class="cit-lpage">1294</span>.</cite></div>
                           <div class="cit-extra"><a href="/cgi/ijlink?linkType=ABST&amp;journalCode=annonc&amp;resid=22/6/1288"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-ijlinks"><span class="cit-reflinks-abstract">Abstract</span><span class="cit-sep cit-reflinks-variant-name-sep">/</span><span class="cit-reflinks-full-text"><span class="free-full-text">FREE </span>Full Text</span></a></div>
                        </div>
                        
                     </li>
                     <li><span class="ref-label">44.</span>
                        
                        
                        <div class="cit ref-cit ref-journal no-rev-xref" id="cit-106.1.djt319.44"
                             data-doi="10.1007/s10549-010-0761-y">
                           <div class="cit-metadata">
                              <ol class="cit-auth-list">
                                 <li><span class="cit-auth"><span class="cit-name-surname">Castellano</span>  <span class="cit-name-given-names">I</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Allia</span>  <span class="cit-name-given-names">E</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Accortanzo</span>  <span class="cit-name-given-names">V</span></span>, 
                                 </li>
                                 <li><span class="cit-etal">et al.</span></li>
                              </ol><cite>
                                 <span class="cit-article-title">Androgen receptor expression is a significant prognostic factor in estrogen receptor positive breast cancers</span>. <abbr class="cit-jnl-abbrev">Breast Cancer Res Treat</abbr>. <span class="cit-pub-date">2010</span>;<span class="cit-vol">124</span>(<span class="cit-issue">3</span>):<span class="cit-fpage">607</span>–<span class="cit-lpage">617</span>.</cite></div>
                           <div class="cit-extra"><a href="/external-ref?access_num=10.1007/s10549-010-0761-y&amp;link_type=DOI"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-webofscience">CrossRef</a><a href="/external-ref?access_num=20127405&amp;link_type=MED"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-medline">Medline</a><a href="/external-ref?access_num=000284508300002&amp;link_type=ISI"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-webofscience">Web of Science</a><a target="_blank"
                                 href="http://scholar.google.com/scholar_lookup?title=Androgen%20receptor%20expression%20is%20a%20significant%20prognostic%20factor%20in%20estrogen%20receptor%20positive%20breast%20cancers&amp;author=I%20Castellano&amp;author=E%20Allia&amp;author=V%20Accortanzo&amp;publication_year=2010&amp;journal=Breast%20Cancer%20Res%20Treat&amp;volume=124&amp;issue=3&amp;pages=607-617">Google Scholar</a></div>
                        </div>
                        
                     </li>
                     <li><span class="ref-label">45.</span>
                        
                        
                        <div class="cit ref-cit ref-journal no-rev-xref" id="cit-106.1.djt319.45">
                           <div class="cit-metadata">
                              <ol class="cit-auth-list">
                                 <li><span class="cit-auth"><span class="cit-name-surname">Gonzalez</span>  <span class="cit-name-given-names">LO</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Corte</span>  <span class="cit-name-given-names">MD</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Vazquez</span>  <span class="cit-name-given-names">J</span></span>, 
                                 </li>
                                 <li><span class="cit-etal">et al.</span></li>
                              </ol><cite>
                                 <span class="cit-article-title">Androgen receptor expresion in breast cancer: relationship with clinicopathological characteristics of the tumors, prognosis,
                                    and expression of metalloproteases and their inhibitors</span>. <abbr class="cit-jnl-abbrev">BMC Cancer</abbr>. <span class="cit-pub-date">2008 May 28;8:149</span>.</cite></div>
                           <div class="cit-extra"><a target="_blank"
                                 href="http://scholar.google.com/scholar_lookup?title=Androgen%20receptor%20expresion%20in%20breast%20cancer%3A%20relationship%20with%20clinicopathological%20characteristics%20of%20the%20tumors%2C%20prognosis%2C%20and%20expression%20of%20metalloproteases%20and%20their%20inhibitors&amp;author=LO%20Gonzalez&amp;author=MD%20Corte&amp;author=J%20Vazquez&amp;publication_year=2008%20May%2028%3B8%3A149&amp;journal=BMC%20Cancer">Google Scholar</a></div>
                        </div>
                        
                     </li>
                     <li><span class="ref-label">46.</span>
                        
                        
                        <div class="cit ref-cit ref-journal no-rev-xref" id="cit-106.1.djt319.46"
                             data-doi="10.1007/s10549-011-1715-8">
                           <div class="cit-metadata">
                              <ol class="cit-auth-list">
                                 <li><span class="cit-auth"><span class="cit-name-surname">Loibl</span>  <span class="cit-name-given-names">S</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Muller</span>  <span class="cit-name-given-names">BM</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">von Minckwitz</span>  <span class="cit-name-given-names">G</span></span>, 
                                 </li>
                                 <li><span class="cit-etal">et al.</span></li>
                              </ol><cite>
                                 <span class="cit-article-title">Androgen receptor expression in primary breast cancer and its predictive and prognostic value in patients treated with neoadjuvant
                                    chemotherapy</span>. <abbr class="cit-jnl-abbrev">Breast Cancer Res Treat</abbr>. <span class="cit-pub-date">2011</span>;<span class="cit-vol">130</span>(<span class="cit-issue">2</span>):<span class="cit-fpage">477</span>–<span class="cit-lpage">487</span>.</cite></div>
                           <div class="cit-extra"><a href="/external-ref?access_num=10.1007/s10549-011-1715-8&amp;link_type=DOI"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-webofscience">CrossRef</a><a href="/external-ref?access_num=21837479&amp;link_type=MED"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-medline">Medline</a><a href="/external-ref?access_num=000295675700012&amp;link_type=ISI"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-webofscience">Web of Science</a><a target="_blank"
                                 href="http://scholar.google.com/scholar_lookup?title=Androgen%20receptor%20expression%20in%20primary%20breast%20cancer%20and%20its%20predictive%20and%20prognostic%20value%20in%20patients%20treated%20with%20neoadjuvant%20chemotherapy&amp;author=S%20Loibl&amp;author=BM%20Muller&amp;author=G%20von%20Minckwitz&amp;publication_year=2011&amp;journal=Breast%20Cancer%20Res%20Treat&amp;volume=130&amp;issue=2&amp;pages=477-487">Google Scholar</a></div>
                        </div>
                        
                     </li>
                     <li><span class="ref-label">47.</span>
                        
                        
                        <div class="cit ref-cit ref-journal no-rev-xref" id="cit-106.1.djt319.47"
                             data-doi="10.5732/cjc.009.10673">
                           <div class="cit-metadata">
                              <ol class="cit-auth-list">
                                 <li><span class="cit-auth"><span class="cit-name-surname">Luo</span>  <span class="cit-name-given-names">X</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Shi</span>  <span class="cit-name-given-names">YX</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Li</span>  <span class="cit-name-given-names">ZM</span></span>, 
                                 </li>
                                 <li><span class="cit-etal">et al.</span></li>
                              </ol><cite>
                                 <span class="cit-article-title">Expression and clinical significance of androgen receptor in triple negative breast cancer</span>. <abbr class="cit-jnl-abbrev">Chin J Cancer</abbr>. <span class="cit-pub-date">2010</span>;<span class="cit-vol">29</span>(<span class="cit-issue">6</span>):<span class="cit-fpage">585</span>–<span class="cit-lpage">590</span>.</cite></div>
                           <div class="cit-extra"><a href="/external-ref?access_num=10.5732/cjc.009.10673&amp;link_type=DOI"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-webofscience">CrossRef</a><a href="/external-ref?access_num=20507730&amp;link_type=MED"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-medline">Medline</a><a target="_blank"
                                 href="http://scholar.google.com/scholar_lookup?title=Expression%20and%20clinical%20significance%20of%20androgen%20receptor%20in%20triple%20negative%20breast%20cancer&amp;author=X%20Luo&amp;author=YX%20Shi&amp;author=ZM%20Li&amp;publication_year=2010&amp;journal=Chin%20J%20Cancer&amp;volume=29&amp;issue=6&amp;pages=585-590">Google Scholar</a></div>
                        </div>
                        
                     </li>
                     <li><span class="ref-label">48.</span>
                        
                        
                        <div class="cit ref-cit ref-journal no-rev-xref" id="cit-106.1.djt319.48"
                             data-doi="10.1007/s00428-010-0964-y">
                           <div class="cit-metadata">
                              <ol class="cit-auth-list">
                                 <li><span class="cit-auth"><span class="cit-name-surname">Micello</span>  <span class="cit-name-given-names">D</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Marando</span>  <span class="cit-name-given-names">A</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Sahnane</span>  <span class="cit-name-given-names">N</span></span>, 
                                 </li>
                                 <li><span class="cit-etal">et al.</span></li>
                              </ol><cite>
                                 <span class="cit-article-title">Androgen receptor is frequently expressed in HER2-positive, ER/PR-negative breast cancers</span>. <abbr class="cit-jnl-abbrev">Virchows Arch</abbr>. <span class="cit-pub-date">2010</span>;<span class="cit-vol">457</span>(<span class="cit-issue">4</span>):<span class="cit-fpage">467</span>–<span class="cit-lpage">476</span>.</cite></div>
                           <div class="cit-extra"><a href="/external-ref?access_num=10.1007/s00428-010-0964-y&amp;link_type=DOI"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-webofscience">CrossRef</a><a href="/external-ref?access_num=20809337&amp;link_type=MED"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-medline">Medline</a><a href="/external-ref?access_num=000282434700008&amp;link_type=ISI"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-webofscience">Web of Science</a><a target="_blank"
                                 href="http://scholar.google.com/scholar_lookup?title=Androgen%20receptor%20is%20frequently%20expressed%20in%20HER2-positive%2C%20ER%2FPR-negative%20breast%20cancers&amp;author=D%20Micello&amp;author=A%20Marando&amp;author=N%20Sahnane&amp;publication_year=2010&amp;journal=Virchows%20Arch&amp;volume=457&amp;issue=4&amp;pages=467-476">Google Scholar</a></div>
                        </div>
                        
                     </li>
                     <li><span class="ref-label">49.</span>
                        
                        
                        <div class="cit ref-cit ref-journal no-rev-xref" id="cit-106.1.djt319.49">
                           <div class="cit-metadata">
                              <ol class="cit-auth-list">
                                 <li><span class="cit-auth"><span class="cit-name-surname">Peters</span>  <span class="cit-name-given-names">KM</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Edwards</span>  <span class="cit-name-given-names">SL</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Nair</span>  <span class="cit-name-given-names">SS</span></span>, 
                                 </li>
                                 <li><span class="cit-etal">et al.</span></li>
                              </ol><cite>
                                 <span class="cit-article-title">Androgen receptor expression predicts breast cancer survival: the role of genetic and epigenetic events</span>. <abbr class="cit-jnl-abbrev">BMC Cancer</abbr>. <span class="cit-pub-date">2012 Apr 2;12:132</span>.</cite></div>
                           <div class="cit-extra"><a target="_blank"
                                 href="http://scholar.google.com/scholar_lookup?title=Androgen%20receptor%20expression%20predicts%20breast%20cancer%20survival%3A%20the%20role%20of%20genetic%20and%20epigenetic%20events&amp;author=KM%20Peters&amp;author=SL%20Edwards&amp;author=SS%20Nair&amp;publication_year=2012%20Apr%202%3B12%3A132&amp;journal=BMC%20Cancer">Google Scholar</a></div>
                        </div>
                        
                     </li>
                     <li><span class="ref-label">50.</span>
                        
                        
                        <div class="cit ref-cit ref-journal no-rev-xref" id="cit-106.1.djt319.50"
                             data-doi="10.1309/42F00D0DJD0J5EDT">
                           <div class="cit-metadata">
                              <ol class="cit-auth-list">
                                 <li><span class="cit-auth"><span class="cit-name-surname">Agoff</span>  <span class="cit-name-given-names">SN</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Swanson</span>  <span class="cit-name-given-names">PE</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Linden</span>  <span class="cit-name-given-names">H</span></span>, 
                                 </li>
                                 <li><span class="cit-etal">et al.</span></li>
                              </ol><cite>
                                 <span class="cit-article-title">Androgen receptor expression in estrogen receptor-negative breast cancer. Immunohistochemical, clinical, and <em>prognostic associations</em>
                                    </span>. <abbr class="cit-jnl-abbrev">Am J Clin Pathol</abbr>. <span class="cit-pub-date">2003</span>;<span class="cit-vol">120</span>(<span class="cit-issue">5</span>):<span class="cit-fpage">725</span>–<span class="cit-lpage">731</span>.</cite></div>
                           <div class="cit-extra"><a href="/cgi/ijlink?linkType=ABST&amp;journalCode=ajcp&amp;resid=120/5/725"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-ijlinks"><span class="cit-reflinks-abstract">Abstract</span><span class="cit-sep cit-reflinks-variant-name-sep">/</span><span class="cit-reflinks-full-text"><span class="free-full-text">FREE </span>Full Text</span></a></div>
                        </div>
                        
                     </li>
                     <li><span class="ref-label">51.</span>
                        
                        
                        <div class="cit ref-cit ref-journal no-rev-xref" id="cit-106.1.djt319.51"
                             data-doi="10.1002/1097-0142(19841201)54:11&lt;2436::AID-CNCR2820541121&gt;3.0.CO;2-H">
                           <div class="cit-metadata">
                              <ol class="cit-auth-list">
                                 <li><span class="cit-auth"><span class="cit-name-surname">Bryan</span>  <span class="cit-name-given-names">RM</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Mercer</span>  <span class="cit-name-given-names">RJ</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Bennett</span>  <span class="cit-name-given-names">RC</span></span>, 
                                 </li>
                                 <li><span class="cit-etal">et al.</span></li>
                              </ol><cite>
                                 <span class="cit-article-title">Androgen receptors in breast cancer</span>. <abbr class="cit-jnl-abbrev">Cancer</abbr>. <span class="cit-pub-date">1984</span>;<span class="cit-vol">54</span>(<span class="cit-issue">11</span>):<span class="cit-fpage">2436</span>–<span class="cit-lpage">2440</span>.</cite></div>
                           <div class="cit-extra"><a href="/external-ref?access_num=10.1002/1097-0142(19841201)54:11%3C2436::AID-CNCR2820541121%3E3.0.CO;2-H&amp;link_type=DOI"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-webofscience">CrossRef</a><a href="/external-ref?access_num=6498736&amp;link_type=MED"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-medline">Medline</a><a href="/external-ref?access_num=A1984TU45200020&amp;link_type=ISI"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-webofscience">Web of Science</a><a target="_blank"
                                 href="http://scholar.google.com/scholar_lookup?title=Androgen%20receptors%20in%20breast%20cancer&amp;author=RM%20Bryan&amp;author=RJ%20Mercer&amp;author=RC%20Bennett&amp;publication_year=1984&amp;journal=Cancer&amp;volume=54&amp;issue=11&amp;pages=2436-2440">Google Scholar</a></div>
                        </div>
                        
                     </li>
                     <li><span class="ref-label">52.</span>
                        
                        
                        <div class="cit ref-cit ref-journal no-rev-xref" id="cit-106.1.djt319.52"
                             data-doi="10.1007/BF02389545">
                           <div class="cit-metadata">
                              <ol class="cit-auth-list">
                                 <li><span class="cit-auth"><span class="cit-name-surname">Langer</span>  <span class="cit-name-given-names">M</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Kubista</span>  <span class="cit-name-given-names">E</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Schemper</span>  <span class="cit-name-given-names">M</span></span>, 
                                 </li>
                                 <li><span class="cit-etal">et al.</span></li>
                              </ol><cite>
                                 <span class="cit-article-title">Androgen receptors, serum androgen levels and survival of breast cancer patients</span>. <abbr class="cit-jnl-abbrev">Arch Gynecol Obstet</abbr>. <span class="cit-pub-date">1990</span>;<span class="cit-vol">247</span>(<span class="cit-issue">4</span>):<span class="cit-fpage">203</span>–<span class="cit-lpage">209</span>.</cite></div>
                           <div class="cit-extra"><a href="/external-ref?access_num=10.1007/BF02389545&amp;link_type=DOI"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-webofscience">CrossRef</a><a href="/external-ref?access_num=2221994&amp;link_type=MED"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-medline">Medline</a><a href="/external-ref?access_num=A1990DQ10100006&amp;link_type=ISI"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-webofscience">Web of Science</a><a target="_blank"
                                 href="http://scholar.google.com/scholar_lookup?title=Androgen%20receptors%2C%20serum%20androgen%20levels%20and%20survival%20of%20breast%20cancer%20patients&amp;author=M%20Langer&amp;author=E%20Kubista&amp;author=M%20Schemper&amp;publication_year=1990&amp;journal=Arch%20Gynecol%20Obstet&amp;volume=247&amp;issue=4&amp;pages=203-209">Google Scholar</a></div>
                        </div>
                        
                     </li>
                     <li><span class="ref-label">53.</span>
                        
                        
                        <div class="cit ref-cit ref-journal no-rev-xref" id="cit-106.1.djt319.53"
                             data-doi="10.1016/S0960-9776(96)90055-7">
                           <div class="cit-metadata">
                              <ol class="cit-auth-list">
                                 <li><span class="cit-auth"><span class="cit-name-surname">Collet</span>  <span class="cit-name-given-names">K</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Maehle</span>  <span class="cit-name-given-names">BO</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Skaerven</span>  <span class="cit-name-given-names">R</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Aas</span>  <span class="cit-name-given-names">T</span></span></li>
                              </ol><cite>. <span class="cit-article-title">Prognostic role of oestrogen, progesterone and androgen receptor in relation to patient age in patients with breast cancer</span>. <abbr class="cit-jnl-abbrev">Breast</abbr>. <span class="cit-pub-date">1996</span>;<span class="cit-vol">5</span>(<span class="cit-issue">3</span>):<span class="cit-fpage">123</span>–<span class="cit-lpage">126</span>.</cite></div>
                           <div class="cit-extra"><a href="/external-ref?access_num=10.1016/S0960-9776(96)90055-7&amp;link_type=DOI"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-webofscience">CrossRef</a><a href="/external-ref?access_num=A1996UX73500002&amp;link_type=ISI"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-webofscience">Web of Science</a><a target="_blank"
                                 href="http://scholar.google.com/scholar_lookup?title=Prognostic%20role%20of%20oestrogen%2C%20progesterone%20and%20androgen%20receptor%20in%20relation%20to%20patient%20age%20in%20patients%20with%20breast%20cancer&amp;author=K%20Collet&amp;author=BO%20Maehle&amp;author=R%20Skaerven&amp;author=T%20Aas&amp;publication_year=1996&amp;journal=Breast&amp;volume=5&amp;issue=3&amp;pages=123-126">Google Scholar</a></div>
                        </div>
                        
                     </li>
                     <li><span class="ref-label">54.</span>
                        
                        
                        <div class="cit ref-cit ref-journal no-rev-xref" id="cit-106.1.djt319.54"
                             data-doi="10.1158/1078-0432.CCR-08-1763">
                           <div class="cit-metadata">
                              <ol class="cit-auth-list">
                                 <li><span class="cit-auth"><span class="cit-name-surname">Gonzalez-Angulo</span>  <span class="cit-name-given-names">AM</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Stemke-Hale</span>  <span class="cit-name-given-names">K</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Palla</span>  <span class="cit-name-given-names">SL</span></span>, 
                                 </li>
                                 <li><span class="cit-etal">et al.</span></li>
                              </ol><cite>
                                 <span class="cit-article-title">Androgen receptor levels and association with PIK3CA mutations and prognosis in breast cancer</span>. <abbr class="cit-jnl-abbrev">Clin Cancer Res</abbr>. <span class="cit-pub-date">2009</span>;<span class="cit-vol">15</span>(<span class="cit-issue">7</span>):<span class="cit-fpage">2472</span>–<span class="cit-lpage">2478</span>.</cite></div>
                           <div class="cit-extra"><a href="/cgi/ijlink?linkType=ABST&amp;journalCode=clincanres&amp;resid=15/7/2472"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-ijlinks"><span class="cit-reflinks-abstract">Abstract</span><span class="cit-sep cit-reflinks-variant-name-sep">/</span><span class="cit-reflinks-full-text"><span class="free-full-text">FREE </span>Full Text</span></a></div>
                        </div>
                        
                     </li>
                  </ol>
               </div><span class="highwire-journal-article-marker-end"></span></div><span id="related-urls"></span></div>
         <div id="col-2">
            
            <div class="article-nav sidebar-nav">
               <a href="/content/105/24/NP.4.short" title="Previous article" class="previous">« Previous</a><span class="article-nav-sep"> | </span><a href="/content/106/1/djt322.short" title="Next article" class="next">Next Article »</a>
               
               <span class="toc-link">
                  				<a href="/content/106/1.toc" title="Table of Contents">Table of Contents</a>
                  			</span>
               
               
            </div>
            <div class="content-box" id="article-cb-main">
               <div class="cb-contents">
                  <h3 class="cb-contents-header"><span>This Article</span></h3>
                  <div class="cb-section cb-slug">
                     <ol>
                        <li>
                           <div id="slugline">
                              
                              <cite>
                                 <abbr title="JNCI Journal of the National Cancer Institute" class="slug-jnl-abbrev">
                                    <nlm:abbrev-journal-title xmlns:nlm="http://schema.highwire.org/NLM/Journal" abbrev-type="publisher">JNCI J Natl Cancer Inst</nlm:abbrev-journal-title></abbr><span class="slug-pub-date" itemprop="datePublished">
                                    (2014) 
                                    </span>
                                 
                                 <span class="slug-vol">
                                    106
                                    </span><span class="slug-issue">
                                    (1):
                                    </span><span class="slug-elocation">
                                    
                                    djt319
                                    </span>
                                 <span class="slug-doi-wrapper">
                                    
                                    doi:
                                    
                                    <span title="10.1093/jnci/djt319" class="slug-doi">10.1093/jnci/djt319</span>
                                    </span>
                                 </cite>
                              
                              
                              <span class="slug-metadata-note ahead-of-print">
                                 
                                 First published online
                                 
                                 <span class="slug-ahead-of-print-date">November 22, 2013</span>
                                 </span>
                              
                              
                              
                              
                              
                              
                              
                              
                              
                           </div>
                        </li>
                     </ol>
                  </div>
                  <div class="cb-section cb-views">
                     <ol>
                        <li class="abstract-view-link primary"><a href="/content/106/1/djt319.abstract" rel="view-abstract">Abstract</a><span class="free">Free</span></li>
                        <li class="notice full-text-view-link"><span class="variant-indicator">» <span>Full Text (HTML)</span></span><span class="free">Free</span></li>
                        <li class="notice full-text-pdf-view-link"><a href="/content/106/1/djt319.full.pdf+html" rel="view-full-text.pdf">Full Text (PDF)</a><span class="free">Free</span></li>
                        <li class="cb-versions">
                           <div><span id="pap-all-versions-label">All Versions of this Article:</span><ol class="version-list">
                                 <li><a href="/content/early/2013/11/20/jnci.djt319">djt319v1</a></li>
                                 <li class="current-li"><span>106/1/djt319</span> <span class="current-version">most recent</span></li>
                              </ol>
                           </div>
                        </li>
                     </ol>
                  </div>
                  <div class="cb-section collapsible" id="cb-art-cat">
                     <h4 class="cb-section-header"><span>Classifications</span></h4>
                     <ol>
                        <li>
                           <ul class="subject-headings last-child">
                              <li><a class="tocsection-search"
                                    href="/search?tocsectionid=Review&amp;sortspec=date&amp;submit=Submit">Review</a></li>
                           </ul>
                        </li>
                     </ol>
                  </div>
                  <div class="cb-section collapsible" id="cb-art-svcs">
                     <h4 class="cb-section-header"><span>Services</span></h4>
                     <ol>
                        <li class="usage-stats-link icon-link"><a href="/articleusage?gca=jnci;106/1/djt319" rel="nofollow">Article metrics</a></li>
                        <li class="alert-link icon-link"><a href="/cgi/alerts/ctalert?alertType=citedby&amp;addAlert=cited_by&amp;cited_by_criteria_resid=jnci%3B106%2F1%2Fdjt319&amp;saveAlert=no&amp;return-type=article&amp;return_url=http://jnci.oxfordjournals.org/content/106/1/djt319.full">Alert me when cited</a></li>
                        <li class="alert-link icon-link"><a href="/cgi/alerts/ctalert?alertType=correction&amp;addAlert=correction&amp;correction_criteria_value=106/1/djt319&amp;saveAlert=no&amp;return-type=article&amp;return_url=http://jnci.oxfordjournals.org/content/106/1/djt319.full">Alert me if corrected</a></li>
                        <li class="similar-link"><a href="/search?qbe=jnci%3Bdjt319&amp;citation=Vera-Badillo%20et%20al.%20106%20%281%29&amp;submit=yes">Find similar articles</a></li>
                        <li class="similar-link"><a href="/external-ref?access_num=jnci%3B106%2F1%2Fdjt319&amp;link_type=ISI_RELATEDRECORDS"
                              id="cb-isi-similar-articles"
                              class="similar-link">Similar articles in Web of Science</a></li>
                        <li class="similar-link"><a href="/external-ref?access_num=24273215&amp;link_type=MED_NBRS"
                              class="similar-link">Similar articles in PubMed</a></li>
                        <li class="folder-link icon-link"><a href="/cgi/folders?action=addtofolder&amp;wherefrom=JOURNALS&amp;wrapped_id=jnci%3B106%2F1%2Fdjt319">Add to my archive</a></li>
                        <li class="cit-man-link icon-link cite-link"><a href="/citmgr?gca=jnci%3B106%2F1%2Fdjt319">Download citation</a></li>
                        <li><a class="request-permissions"
                              href="https://s100.copyright.com/AppDispatchServlet?publisherName=oup&amp;publication=jnci&amp;title=Androgen%20Receptor%20Expression%20and%20Outcomes%20in%20Early%20Breast%20Cancer%3A%20A%20Systematic%20Review%20and%20Meta-Analysis%3A%20&amp;publicationDate=01%2F01%2F2014&amp;author=Francisco%20E.%20Vera-Badillo%2C%20Arnoud%20J.%20Templeton%2C%20Paulo%20de%20Gouveia%2C%20Ivan%20Diaz-Padilla%2C%20Philippe%20L.%20Bedard%2C%20Mustafa%20Al-Mubarak%2C%20Bostjan%20Seruga%2C%20Ian%20F.%20Tannock%2C%20Alberto%20Ocana%2C%20Eitan%20Amir&amp;copyright=Oxford%20University%20Press&amp;contentID=10.1093%2Fjnci%2Fdjt319&amp;volumeNum=106&amp;issueNum=1&amp;startPage=&amp;endPage=&amp;orderBeanReset=true"
                              target="_blank">Request Permissions</a></li>
                     </ol>
                  </div>
                  <div class="cb-section collapsible default-closed" id="cb-art-cit">
                     <h4 class="cb-section-header"><span>Citing Articles</span></h4>
                     <ol>
                        <li class="hw-citing-link"><a href="/content/106/1/djt319.full?cited-by=yes&amp;legid=jnci;106/1/djt319#cited-by"
                              id="cb-hw-citing-articles">Load citing article information</a></li>
                        <li><a href="/cgi/crossref-forward-links/106/1/djt319" rel="external-nw"
                              id="cb-crossref-citing-articles">Citing articles via CrossRef</a></li>
                        <li><a href="/scopus-links/jnci/106/1/djt319?access_num=/jnci/106/1/djt319"
                              rel="external-nw"
                              id="cb-scopus-citing-articles">Citing articles via Scopus</a></li>
                        <li><a href="/external-ref?access_num=%2Fjnci%2F106%2F1%2Fdjt319&amp;link_type=ISI_CITING&amp;accnum_type=native"
                              rel="external-nw"
                              id="cb-isi-citing-articles">Citing articles via Web of Science</a></li>
                        <li><a href="/external-ref?access_num=http://jnci.oxfordjournals.org/content/106/1/djt319.abstract&amp;link_type=GOOGLESCHOLAR">Citing articles via Google Scholar</a></li>
                     </ol>
                  </div>
                  <div class="cb-section collapsible default-closed" id="cb-art-gs">
                     <h4 class="cb-section-header"><span>Google Scholar</span></h4>
                     <ol>
                        <li class="cb-art-gs-auth author-link"><a href="http://scholar.google.com/scholar?q=%22author%3AVera-Badillo%20author%3AF.E.%22"
                              class="cb-art-gs-auth author-link">Articles by  Vera-Badillo, F. E.</a></li>
                        <li class="cb-art-gs-auth author-link"><a href="http://scholar.google.com/scholar?q=%22author%3AAmir%20author%3AE.%22"
                              class="cb-art-gs-auth author-link">Articles by  Amir, E.</a></li>
                        <li class="cb-art-gs-rel similar-link"><a href="/external-ref?access_num=http://jnci.oxfordjournals.org/content/106/1/djt319.abstract&amp;link_type=GOOGLESCHOLARRELATED">Search for related content</a></li>
                     </ol>
                  </div>
                  <div class="cb-section collapsible default-closed" id="cb-art-pm">
                     <h4 class="cb-section-header"><span>PubMed</span></h4>
                     <ol>
                        <li class="cb-art-pm-cite cite-link icon-link"><a href="/external-ref?access_num=24273215&amp;link_type=PUBMED"
                              class="cb-art-pm-cite cite-link icon-link">PubMed citation</a></li>
                        <li class="cb-art-pm-auth author-link"><a href="/external-ref?access_num=Vera-Badillo%20FE&amp;link_type=AUTHORSEARCH"
                              class="cb-art-pm-auth author-link">Articles by  Vera-Badillo, F. E.</a></li>
                        <li class="cb-art-pm-auth author-link"><a href="/external-ref?access_num=Templeton%20AJ&amp;link_type=AUTHORSEARCH"
                              class="cb-art-pm-auth author-link">Articles by  Templeton, A. J.</a></li>
                        <li class="cb-art-pm-auth author-link"><a href="/external-ref?access_num=de%20Gouveia%20P&amp;link_type=AUTHORSEARCH"
                              class="cb-art-pm-auth author-link">Articles by  de Gouveia, P.</a></li>
                        <li class="cb-art-pm-auth author-link"><a href="/external-ref?access_num=Diaz-Padilla%20I&amp;link_type=AUTHORSEARCH"
                              class="cb-art-pm-auth author-link">Articles by  Diaz-Padilla, I.</a></li>
                        <li class="cb-art-pm-auth author-link"><a href="/external-ref?access_num=Bedard%20PL&amp;link_type=AUTHORSEARCH"
                              class="cb-art-pm-auth author-link">Articles by  Bedard, P. L.</a></li>
                        <li class="cb-art-pm-auth author-link"><a href="/external-ref?access_num=Al-Mubarak%20M&amp;link_type=AUTHORSEARCH"
                              class="cb-art-pm-auth author-link">Articles by  Al-Mubarak, M.</a></li>
                        <li class="cb-art-pm-auth author-link"><a href="/external-ref?access_num=Seruga%20B&amp;link_type=AUTHORSEARCH"
                              class="cb-art-pm-auth author-link">Articles by  Seruga, B.</a></li>
                        <li class="cb-art-pm-auth author-link"><a href="/external-ref?access_num=Tannock%20IF&amp;link_type=AUTHORSEARCH"
                              class="cb-art-pm-auth author-link">Articles by  Tannock, I. F.</a></li>
                        <li class="cb-art-pm-auth author-link"><a href="/external-ref?access_num=Ocana%20A&amp;link_type=AUTHORSEARCH"
                              class="cb-art-pm-auth author-link">Articles by  Ocana, A.</a></li>
                        <li class="cb-art-pm-auth author-link"><a href="/external-ref?access_num=Amir%20E&amp;link_type=AUTHORSEARCH"
                              class="cb-art-pm-auth author-link">Articles by  Amir, E.</a></li>
                     </ol>
                  </div>
                  <div class="cb-section collapsible default-closed" id="cb-art-rel">
                     <h4 class="cb-section-header"><span>Related Content</span></h4>
                     <ol>
                        <li><a href="/content/106/1/djt319.full?related-urls=yes&amp;legid=jnci;106/1/djt319#related-urls"
                              id="cb-related-urls">Load related web page information</a></li>
                     </ol>
                  </div>
                  <div class="cb-section collapsible" id="cb-art-soc">
                     <h4 class="cb-section-header"><span>Share</span></h4>
                     <ol>
                        <li><a href="/email?gca=jnci%3B106%2F1%2Fdjt319&amp;current-view-path=/content/106/1/djt319.full">
                              Email this article</a></li>
                        <li>
                           <div class="social-bookmarking">
                              
                              <ul class="social-bookmark-links">
                                 <li class="social-bookmarking-item social-bookmarking-item-citeulike"><a href="/external-ref?tag_url=http://jnci.oxfordjournals.org/cgi/content/long/106/1/djt319&amp;title=Androgen%20Receptor%20Expression%20and%20Outcomes%20in%20Early%20Breast%20Cancer%3A%20A%20Systematic%20Review%20and%20Meta-Analysis+--+Vera-Badillo%20et%20al.%20106%20%281%29+--+jnci.j&amp;doi=10.1093/jnci/djt319&amp;link_type=CITEULIKE"><img src="/shared/img/common/social-bookmarking/citeulike.gif"
                                            alt="Add to CiteULike"
                                            title="CiteULike" /></a><span class="soc-bm-link-text">CiteULike</span></li>
                                 <li class="social-bookmarking-item social-bookmarking-item-delicious"><a href="/external-ref?tag_url=http://jnci.oxfordjournals.org/cgi/content/long/106/1/djt319&amp;title=Androgen%20Receptor%20Expression%20and%20Outcomes%20in%20Early%20Breast%20Cancer%3A%20A%20Systematic%20Review%20and%20Meta-Analysis+--+Vera-Badillo%20et%20al.%20106%20%281%29+--+jnci.j&amp;doi=10.1093/jnci/djt319&amp;link_type=DEL_ICIO_US"><img src="/shared/img/common/social-bookmarking/delicious.gif"
                                            alt="Add to Delicious"
                                            title="Delicious" /></a><span class="soc-bm-link-text">Delicious</span></li>
                                 <li class="social-bookmarking-item social-bookmarking-item-facebook"><a href="/external-ref?tag_url=http://jnci.oxfordjournals.org/cgi/content/short/106/1/djt319&amp;title=Androgen%20Receptor%20Expression%20and%20Outcomes%20in%20Early%20Breast%20Cancer%3A%20A%20Systematic%20Review%20and%20Meta-Analysis+--+Vera-Badillo%20et%20al.%20106%20%281%29+--+jnci.j&amp;doi=10.1093/jnci/djt319&amp;link_type=FACEBOOK"
                                       class="sb-facebook"
                                       rel="external-nw"><img src="/shared/img/common/social-bookmarking/facebook.gif" alt="Add to Facebook"
                                            title="Facebook" /></a><span class="soc-bm-link-text">Facebook</span></li>
                                 <li class="social-bookmarking-item social-bookmarking-item-googleplus"><a href="/external-ref?tag_url=http://jnci.oxfordjournals.org/cgi/content/long/106/1/djt319&amp;title=Androgen%20Receptor%20Expression%20and%20Outcomes%20in%20Early%20Breast%20Cancer%3A%20A%20Systematic%20Review%20and%20Meta-Analysis+--+Vera-Badillo%20et%20al.%20106%20%281%29+--+jnci.j&amp;doi=10.1093/jnci/djt319&amp;link_type=GOOGLEPLUS&amp;log_only=yes"><img src="/shared/img/common/social-bookmarking/googleplus.jpg" alt="Add to Google+"
                                            title="Google+" /></a><span class="soc-bm-link-text">Google+</span></li>
                                 <li class="social-bookmarking-item social-bookmarking-item-mendeley"><a href="/external-ref?tag_url=http://jnci.oxfordjournals.org/cgi/content/long/106/1/djt319&amp;title=Androgen%20Receptor%20Expression%20and%20Outcomes%20in%20Early%20Breast%20Cancer%3A%20A%20Systematic%20Review%20and%20Meta-Analysis+--+Vera-Badillo%20et%20al.%20106%20%281%29+--+jnci.j&amp;doi=10.1093/jnci/djt319&amp;link_type=MENDELEY"><img src="/shared/img/common/social-bookmarking/mendeley.gif" alt="Add to Mendeley"
                                            title="Mendeley" /></a><span class="soc-bm-link-text">Mendeley</span></li>
                                 <li class="social-bookmarking-item social-bookmarking-item-twitter"><a href="/external-ref?tag_url=http://jnci.oxfordjournals.org/cgi/content/long/106/1/djt319&amp;title=Androgen%20Receptor%20Expression%20and%20Outcomes%20in%20Early%20Breast%20Cancer%3A%20A%20Systematic%20Review%20and%20Meta-Analysis+--+Vera-Badillo%20et%20al.%20106%20%281%29+--+jnci.j&amp;doi=10.1093/jnci/djt319&amp;link_type=TWITTER"><img src="/shared/img/common/social-bookmarking/twitter.gif" alt="Add to Twitter"
                                            title="Twitter" /></a><span class="soc-bm-link-text">Twitter</span></li>
                              </ul>
                              
                              <p class="social-bookmarking-help"><a href="/help/social_bookmarks.dtl">What's this?</a></p>
                              
                           </div>
                        </li>
                     </ol>
                  </div>
               </div>
            </div>
            
            
            <div class="content-box" id="article-dyn-nav">
               <div class="cb-contents">
                  <h3 class="cb-contents-header"><span>Navigate This Article</span></h3>
                  <div class="cb-section" id="cb-art-nav">
                     <ol>
                        <li><a href="#content-block">Top</a></li>
                        <li><a href="#abstract-1">Abstract</a></li>
                        <li><a href="#sec-5">Methods</a></li>
                        <li><a href="#sec-11">Results</a></li>
                        <li><a href="#sec-15">Discussion</a></li>
                        <li><a href="#sec-16">Funding</a></li>
                        <li><a href="#notes-1">Notes</a></li>
                        <li><a href="#ref-list-1">References</a></li>
                     </ol>
                  </div>
               </div>
            </div>
            
         </div>
         <div id="col-3">
            
            <div id="col-3-qs" class="sidebar-qs">
               
               
               <form class="searchbox" action="/search" method="get">
                  <p>Search this journal:</p>
                  <div>
                     	
                     	
                     	<input value="" type="text" name="fulltext" id="header-qs-input" />
                     <input type="hidden" name="submit" value="yes" />
                     
                     <input class="inline_button" type="image" alt="Go" src="/publisher/img/buttons/go.gif" />
                     
                     <div class="adv-search-link"><a href="/search">Advanced »</a></div>
                     
                     
                  </div>
               </form>
               
            </div>
            <div class="cb-contents">
               
               <div id="sidebar-current-issue" class="content-box">
                  	
                  <h3 class="cb-contents-header">Current Issue</h3>
                  	
                  <div class="cb-section">
                     	  
                     <ol>
                        <li>
                           	      <a href="/content/current"><span>
                                 		  <span class="current-issue-date">
                                    October 2015
                                    </span><span class="toc-citation-volume">
                                    
                                    107
                                    </span><span class="toc-citation-issue">(10)</span>
                                 		  
                                 		</span></a>
                           	    
                        </li>
                     </ol>
                     	
                  </div>
                  	
                  <div class="cb-section">
                     	  
                     <ol>
                        <li>
                           <a href="/content/current"><img src="/content/107/10.cover.gif" alt="JNCI J Natl Cancer Inst" id="cover" /></a>
                           
                        </li>
                     </ol>
                     	
                  </div>
                  	
                  <div class="cb-section sidebar-etoc-link">
                     	  
                     <ol>
                        <li><a href="/cgi/alerts/etoc">Alert me to new issues</a></li>
                     </ol>
                     	
                  </div>
                  
               </div>
               
            </div>
            
            <div id="second">
               
               <div class="ad_hidden" id="oas_right1">
                  <iframe id="id_advertframe_right1"
                          src="/resource/htmlfiles/advert.html?p=Right1&amp;u=jnci.oxfordjournals.org/content/106/1/djt319.full"
                          width="0"
                          height="0"
                          frameborder="0"
                          scrolling="no"
                          class="resize_ad"></iframe>
                  
               </div>
               
               <div class="features">
                  
                  <div class="feature separator_after first">
                     
                     <h2 id="the_journal" title="The Journal"><span>The Journal</span></h2>
                     
                     <ul class="emphasised">
                        <li>
                           <a href="http://www.oxfordjournals.org/our_journals/jnci/about.html" rel=""
                              title="About this journal">About this journal</a>
                           
                        </li>
                        <li>
                           <a href="http://www.oxfordjournals.org/our_journals/jnci/contact_us.html" rel=""
                              title="Contact Us">Contact Us</a>
                           
                        </li>
                        <li>
                           <a href="http://www.oxfordjournals.org/access_purchase/rights_permissions.html"
                              rel=""
                              title="Rights &amp; Permissions">Rights &amp; Permissions</a>
                           
                        </li>
                        <li>
                           <a href="HTTP://www.oxfordjournals.org/access_purchase/dispatch_dates.html#JNCI.JP"
                              rel=""
                              title="Dispatch date of next issue">Dispatch date of next issue</a>
                           
                        </li>
                        <li>
                           <a href="http://publicationethics.org/" rel=""
                              title="This journal is a member of the Committee on Publication Ethics (COPE)">This journal is a member of the Committee on Publication Ethics (COPE)</a>
                           
                        </li>
                        <li>
                           <a href="http://www.oxfordjournals.org/mobile_faqs.html" rel=""
                              title="We are mobile – find out more">We are mobile – find out more</a>
                           
                        </li>
                        <li>
                           <a href="http://medicine-and-health-careernetwork.oxfordjournals.org/jobseeker/search/results/?t730=&amp;t732=469986&amp;t731=&amp;t733=&amp;t735=&amp;t737=&amp;max=25&amp;site_id=20102"
                              rel=""
                              title="Journals Career Network">Journals Career Network</a>
                           
                        </li>
                     </ul>
                     
                     <p>
                        <a href="http://www.oxfordjournals.org/our_journals/jnci/episodes_2012.html">
                           <img alt="Podcast Logo" style="float:left"
                                src="http://www.oxfordjournals.org/podcasts/podcast_icon_35x35.gif" />JNCI Podcast</a>
                        <br />
                        <br />
                        
                     </p>
                     
                  </div>
                  
                  <div class="feature separator_after">
                     
                     <h3>Connect with us!</h3>
                     <a href="https://twitter.com/JNCI_Now">
                        <img class="small_margin" alt="Connect with us on Twitter!"
                             src="http://www.oxfordjournals.org/our_journals/phisci/connect_twitter.png"
                             style="vertical-align: top; float: left; " />
                        </a>
                     <a href="https://www.facebook.com/thejnci">
                        <img class="small_margin" alt="Connect with us on Facebook!"
                             src="http://www.oxfordjournals.org/our_journals/phisci/facebook.png"
                             style="vertical-align: top; float: left; " />
                        </a>
                     
                     <p>
                        <br />
                        <br />
                        
                     </p>
                     
                  </div>
                  
                  <div class="feature separator_after">
                     
                     <h3>Editor-in-Chief</h3>
                     
                     <p>Carmen J. Allegra</p>
                     
                     <ul class="emphasised">
                        <li>
                           <a href="http://www.oxfordjournals.org/our_journals/jnci/editorial_board.html"
                              rel=""
                              title="View full editorial board">View full editorial board</a>
                           
                        </li>
                     </ul>
                     
                  </div>
                  
                  <div class="feature separator_after">
                     
                     <h3>Impact factor: 12.583</h3>
                     
                     <h3 class="five_year">5-Yr impact factor: 13.584</h3>
                     
                  </div>
                  
                  <div class="feature">
                     
                     <h3>For the Media</h3>
                     
                     <ul class="emphasised">
                        <li>
                           <a href="http://www.oxfordjournals.org/our_journals/jnci/press_room.html" rel=""
                              title="JNCI PRESS ROOM">JNCI PRESS ROOM</a>
                           
                        </li>
                     </ul>
                     
                  </div>
                  
                  <div class="feature">
                     
                     <h2 id="for_authors" title="For Authors"><span>For Authors</span></h2>
                     
                     <ul class="emphasised">
                        <li>
                           <a href="http://www.oxfordjournals.org/our_journals/jnci/for_authors/index.html"
                              rel=""
                              title="Instructions to authors">Instructions to authors</a>
                           
                        </li>
                        <li>
                           <a href="http://www.oxfordjournals.org/access_purchase/self-archiving_policyb.html"
                              rel=""
                              title="Self Archiving/Public Access Policy">Self Archiving/Public Access Policy</a>
                           
                        </li>
                     </ul>
                     <a href="http://www.oxfordjournals.org/oxfordopen/ ">
                        <img alt="Open access options for authors - visit Oxford Open"
                             src="http://www.oxfordjournals.org/resource/image/promos/oxford_open_small.gif" />
                        </a>
                     <a href="http://www.oxfordjournals.org/oxfordopen/funder_policies/">
                        <img alt="RCUK Wellcome Trust Open Access"
                             src="http://www.oxfordjournals.org/resource/image/wellcome-trust-180x100.jpg" />
                        </a>
                     
                     <p>Open access options for authors - visit <a href="http://www.oxfordjournals.org/oxfordopen/">Oxford Open</a>
                        
                     </p>
                     <a href="http://publicaccess.nih.gov/submit_process_journals.htm">
                        <img alt="PMC Logo" src="http://www.oxfordjournals.org/resource/image/pmc-logo.gif" />
                        </a>
                     
                     <ul class="emphasised">
                        <li>
                           <a href="http://publicaccess.nih.gov/submit_process_journals.htm" rel=""
                              title="This journal enables compliance with the NIH Public Access Policy">This journal enables compliance with the NIH Public Access Policy</a>
                           
                        </li>
                     </ul>
                     
                  </div>
                  
                  <div class="feature">
                     
                     <h2 id="alerting_services" title="Alerting Services"><span>Alerting Services</span></h2>
                     
                     <ul class="emphasised">
                        <li>
                           <a href="/cgi/alerts/etoc" rel="" title="Email table of contents">Email table of contents</a>
                           
                        </li>
                        <li>
                           <a href="/cgi/alerts/etoc" rel="" title="Email Advance Access">Email Advance Access</a>
                           
                        </li>
                        <li>
                           <a href="http://jnci.oxfordjournals.org/help/citetrack/index.dtl" rel=""
                              title="CiteTrack">CiteTrack</a>
                           
                        </li>
                        <li>
                           <a href="/rss" rel="" title="XML RSS feed">XML RSS feed</a>
                           
                        </li>
                     </ul>
                     
                  </div>
                  
                  <div class="feature">
                     
                     <h2 id="corporate_services" title="Corporate Services"><span>Corporate Services</span></h2>
                     
                     <ul class="emphasised">
                        <li>
                           <a href="http://www.oxfordjournals.org/corporate_services/advertising.html" rel=""
                              title="Advertising sales">Advertising sales</a>
                           
                        </li>
                        <li>
                           <a href="http://www.oxfordjournals.org/corporate_services/reprints.html" rel=""
                              title="Reprints">Reprints</a>
                           
                        </li>
                        <li>
                           <a href="http://www.oxfordjournals.org/corporate_services/classifiedadinprint.html"
                              rel=""
                              title="Classified Advertising">Classified Advertising</a>
                           
                        </li>
                     </ul>
                     
                  </div>
                  
               </div>
               <script type="text/javascript">var taxonomies = ["MED00300"];</script>
               </div>
            
            <div class="most-links-box js-marker">
               
               <div class="most-header">
                  
                  <h3>Most</h3>
                  
               </div>
               
               <ul>
                  <li class="most-cur-sel">
                     <h4>Most Read</h4>
                     	  
                     <div class="most-list">
                        	    
                        <ol>
                           <li class="first-item"><a href="http://jnci.oxfordjournals.org/cgi/content/short/92/6/443?rss=1&amp;ssource=mfr">Breast Density and Cancer Risk: What Is the Relationship?</a></li>
                           <li><a href="http://jnci.oxfordjournals.org/cgi/content/short/90/9/713?rss=1&amp;ssource=mfr">The Female Prostate</a></li>
                           <li><a href="http://jnci.oxfordjournals.org/cgi/content/short/91/14/1194?rss=1&amp;ssource=mfr">Tobacco Smoke Carcinogens and Lung Cancer</a></li>
                           <li><a href="http://jnci.oxfordjournals.org/cgi/content/short/107/6/djv048?rss=1&amp;ssource=mfr">Annual Report to the Nation on the Status of Cancer, 1975-2011, Featuring Incidence of Breast Cancer Subtypes by Race/Ethnicity,
                                 Poverty, and State</a></li>
                           <li class="last-item"><a href="http://jnci.oxfordjournals.org/cgi/content/short/105/23/1799?rss=1&amp;ssource=mfr">Elevated Plasma Vitamin B12 Levels as a Marker for Cancer: A Population-Based Cohort Study</a></li>
                        </ol>
                        	    <a href="http://jnci.oxfordjournals.org/reports/mfr1.dtl" class="view-all">» View all Most Read articles</a>
                        	  
                     </div>
                     	
                  </li>
                  <li>
                     <h4>Most Cited</h4>
                     	
                     <div class="most-list">
                        	  
                        <ol>
                           <li class="first-item"><a href="http://jnci.oxfordjournals.org/cgi/content/short/92/3/205?rss=1&amp;ssource=mfc">New Guidelines to Evaluate the Response to Treatment in Solid Tumors</a></li>
                           <li><a href="http://jnci.oxfordjournals.org/cgi/content/short/90/18/1371?rss=1&amp;ssource=mfc">Tamoxifen for Prevention of Breast Cancer: Report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study</a></li>
                           <li><a href="http://jnci.oxfordjournals.org/cgi/content/short/85/5/365?rss=1&amp;ssource=mfc">The European Organization for Research and Treatment of Cancer QLQ-C30: A Quality-of-Life Instrument for Use in International
                                 Clinical Trials in Oncology</a></li>
                           <li><a href="http://jnci.oxfordjournals.org/cgi/content/short/82/13/1107?rss=1&amp;ssource=mfc">New Colorimetric Cytotoxicity Assay for Anticancer-Drug Screening</a></li>
                           <li class="last-item"><a href="http://jnci.oxfordjournals.org/cgi/content/short/82/1/4?rss=1&amp;ssource=mfc">What Is the Evidence That Tumors Are Angiogenesis Dependent?</a></li>
                        </ol>
                        	  <a href="http://jnci.oxfordjournals.org/reports/mfc1.dtl" class="view-all">» View all Most Cited articles</a>
                        	
                     </div>
                     
                  </li>
               </ul>
               
            </div>
            
            
            
         </div>
         
         
         
         <div id="oas_bottom" class="ad_hidden">
            <iframe id="id_advertframe_bottom"
                    src="/resource/htmlfiles/advert.html?p=Bottom&amp;u=jnci.oxfordjournals.org/content/106/1/djt319.full"
                    width="0"
                    height="0"
                    frameborder="0"
                    scrolling="no"
                    class="resize_ad"></iframe>
            
         </div>
         
         
         
         
         
         
         <div id="secondary_footer">
            
            <div id="issn">Online ISSN 1460-2105 - Print ISSN 0027-8874</div>
            
            
            <div id="copyright"><a href="http://www.oxfordjournals.org/our_journals/terms.html">Copyright ©</a> 
               <span>2015</span> Oxford University Press
               
            </div>
            
         </div>
         
         <div id="primary_footer">
            
            <div id="site_logo">
               <strong><span>Oxford Journals</span></strong>
               <em><span>Oxford University Press</span></em>
               
            </div>
            
            
            <div id="third_nav">
               
               <ul>
                  <li><a href="http://www.oxfordjournals.org/site_map.html">Site Map</a></li>
                  <li><a href="http://www.oxfordjournals.org/legal/privacy_policy.html">Privacy Policy</a></li>
                  <li><a href="http://global.oup.com/cookiepolicy/?siteid=journals">Cookie Policy</a></li>
                  <li><a href="http://www.oxfordjournals.org/legal/legal_notices.html">Legal Notices</a></li>
                  <li><a href="http://www.oxfordjournals.org/faq/">Frequently Asked Questions</a></li>
               </ul>
               
            </div>
            
            
            <div id="other_oup_sites">
               
               <form action="http://www.oxfordjournals.org/service/redirect">
                  <div>
                     <label for="site_list">Other Oxford University Press sites:</label>
                     <select name="url" id="site_list">
                        <option value="http://www.oup.com">Oxford University Press</option>
                        <option value="http://www.oxfordjournals.org/china/">Oxford Journals China</option>
                        <option value="http://www.oxfordjournals.org/japan/">Oxford Journals Japan</option>
                        <option value="http://www.oup.com/uk/academic">Academic &amp; Professional books</option>
                        <option value="http://www.oup.com/oxed">Children's &amp; Schools Books</option>
                        <option value="http://www.oup.com/uk/dictionaries">Dictionaries &amp; Reference</option>
                        <option value="http://www.oup.co.uk/newdnb/">Dictionary of National Biography</option>
                        <option value="http://www.oup.com/uk/digital_reference">Digital Reference</option>
                        <option value="http://www.oup.com/elt/">English Language Teaching</option>
                        <option value="http://www.oup.com/uk/textbooks">Higher Education Textbooks</option>
                        <option value="http://www.oup.co.uk/ieu/">International Education Unit</option>
                        <option value="http://www.oup.com/uk/law">Law</option>
                        <option value="http://www.oup.com/uk/medicine">Medicine</option>
                        <option value="http://www.oup.com/uk/music">Music</option>
                        <option value="http://www.oup.com/online">Online Products &amp; Publishing</option>
                        <option value="http://oxfordbibliographiesonline.com">Oxford Bibliographies Online</option>
                        <option value="http://oxforddictionaries.com">Oxford Dictionaries Online</option>
                        <option value="http://www.oed.com">Oxford English Dictionary</option>
                        <option value="http://www.oxfordlanguagedictionaries.com">Oxford Language Dictionaries Online</option>
                        <option value="http://www.oxfordscholarship.com">Oxford Scholarship Online</option>
                        <option value="http://www.oup.com/uk/reference">Reference</option>
                        <option value="http://www.oup.com/uk/rights">Rights and Permissions</option>
                        <option value="http://www.oup.com/uk/booksellers">Resources for Retailers &amp; Wholesalers</option>
                        <option value="http://www.oup.com/uk/corporate">Resources for the Healthcare Industry</option>
                        <option value="http://www.oup.com/vsi">Very Short Introductions</option>
                        <option value="http://www.oup.com/worldsclassics">World's Classics</option></select>
                     
                     <input type="image" src="/resource/image/buttons/go.gif" alt="Go"
                            class="inline_button" />
                     
                  </div>
               </form>
               
            </div>
            
         </div>
         <script type="text/javascript"
                 src="http://gab.cookie.oup.com/aws-cookie/oup.cookiepolicy.pack.js"
                 defer="defer"></script>
         
         <script defer="defer"
                 src="http://oi-underbar.ifactory.com/underbar/js/jquery-ui.min.js"
                 type="text/javascript"></script>
         <script defer="defer"
                 src="http://oi-underbar.ifactory.com/underbar/js/jcarousellite.js"
                 type="text/javascript"></script>
         <script defer="defer"
                 src="http://oi-underbar.ifactory.com/underbar/js/pf_oiunderbarinit.js"
                 type="text/javascript"></script>
         <script defer="defer" src="/resource/js/underbar_local.js" type="text/javascript"></script>
         <script defer="defer" type="text/javascript">
    function fnc_onDomLoaded() {
        var query_context = getQueryContext();
        PF_initOIUnderbar(query_context,":QS:default","","JRN"); 
        PF_insertOIUnderbar(0);
    };
    if (window.addEventListener) { 
        window.addEventListener('load', fnc_onDomLoaded, false); 
    } else if (window.attachEvent) { 
        window.attachEvent('onload', fnc_onDomLoaded); 
    } 
</script>
         <noscript><img src="//ouptag.scholarlyiq.com/ntpagetag.gif?js=0" height="1" width="1"
                 border="0"
                 hspace="0"
                 vspace="0"
                 alt="" /></noscript><script type="text/javascript" src="//ouptag.scholarlyiq.com/ntpagetag.js"></script><script type="text/javascript">
        var gaJsHost = (("https:" == document.location.protocol) ? "https://ssl." : "http://www.");
        document.write(unescape("%3Cscript src='" + gaJsHost + "google-analytics.com/ga.js' type='text/javascript'%3E%3C/script%3E"));
        </script><script type="text/javascript">
        try {
        var pageTracker = _gat._getTracker("UA-189672-16");
        pageTracker._setDomainName(".oxfordjournals.org");
        pageTracker._trackPageview();
        } catch(err) {}
        </script></div>
   </body>
</html>